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Abstract  
 
In the struggle between viruses and host cells, taking control over the cell’s death machinery is 
very crucial for survival.  Several viruses, including human cytomegalovirus (HCMV) induce 
Endoplasmic Reticulum (ER) stress and activate UPR signaling.  While different aspects of ER 
stress and HCMV were studied earlier, the influence of ER stress on the assembly complex was 
hardly illuminated.  This work focuses on one aspect of the viral life cycle in respect to cellular 
ER stress.  Viral assembly complex is the site, where variable viral proteins are assembled to 
start the journey of building progeny viruses.  Due to the 96 hours long life cycle of HCMV, the 
virus needs to keep the cell functioning at least for its life cycle period and avoid any detrimental 
effects of cellular stress.  . 
We used Thapsigargin as an inducer for ER stress in HCMV infected cells versus mock infected 
cells.  Human foreskin fibroblasts (HFF) were used for infection assays as the main successful 
model for infection with HCMV lab isolates.  Wildtype HCMV lab isolates AD169 and the 
UL97 deleti
serine/threonine kinase and the target of anti viral drugs, was shown earlier to be involved in 
phosphorylation of viral and cellular proteins to facilitate infection.  Our investigations showed 
that ER stress affected the assembly site and viral assembly proteins.  Further experiments re-
vealed that the only viral kinase (pUL97) was involved in the modulation of the ER stress lead-
ing to the detected consequences on the assembly complex, viral titer and viral load.  The conse-
quences on the assembly complex were verified by detecting viral assembly protein pp65 via 
western blot, which revealed drastic effects on this major tegument protein.  The ER stress mark-
er BIP was clearly induced in our system and its induction was proportional with the effects de-
tected in assembly complex.   
ER stress is a scientific field of its own; the involvement of viruses with this massive cellular re-
sponse had shed the light on various aspects in the research of viral/cellular interaction and in the 
aspect and potential of the infection under such cellular circumstances.  The data presented here 
are a clear evidence for the involvement of viral assembly proteins in the ER stress, modulated 
by UL97. 
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Chapter One 
Introduction 
1.1 Historical background 
Herpes Viruses have been prevalent as early as ancient Greek times (Nahmias etal., 1968; Wildy, 
1973).  Hippocrates described the cutaneous spreading of herpes simplex lesions and scholars of 
Greek civilization define the Greek word "herpes" to mean "to creep or crawl" in reference the 
spreading nature of the herpetic skin lesions (Nahmias etal., 1968; Wildy, 1973).  In Romeo and 
Juliet, Shakespeare wrote Queen Mob to say “O'er ladies lips, who straight on kisses dream, 
which oft the angry Mab with blisters plagues because their breaths with sweetmeats tainted are” 
(The Tragedy of Romeo and Juliet, act 1 scene4, Mocarski., 2007).  Astruc, a physician of the 
King of France, identified herpes as a cause of genital infection in the 18th century (Hutfield et 
al., 1966).  Ribbert et al. described enlarged cells in the kidneys of a stillborn, without realizing 
the fact that he had just isolated HCMV infected cells (Ribbert et al., 1904).  Vidal was the first 
to report human-to-human transmission of HSV infections, identifying the necessity of intimate 
human contact for spread of infection (Wildy, 1973). 
1.2 classifications of Herpesviruses 
Herpesviruses belong to the order Herpesvirales, which is divided into 3 main families; 
Herpesviridae under which mammals, reptiles and bird viruses are located, Alloherpesviridae for 
fish and frog viruses and Malacoherpesviridae for a bivalve virus (Davison, 2010).  
Herpesviridae is subdivided into 3 subfamilies based mainly on biological properties. 
Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae (Matthews, 1979).  These 
subfamilies are furthermore divided into different genus.   
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Herpes viruses are mainly known with common names which are widely accepted, however all 
these viruses have taxon names (Davison, 2010). The taxon name is an abbreviation of three 
parts: The first part is the infected host; i.e. human (h), the second is the word herpes (h), the 
third is virus (v) and finally an Arabic number was added, which doesn’t imply any meaning 
about taxonomic or biological properties of the virus.  
1.2.1 Alphaherpesvirinae  
The members of Alphaherpesvirinae are distinguished for infect variable hosts, causing efficient 
destruction of infected cells with relatively short reproductive cycle, and ability to establish 
latent infections primarily in sensory ganglia. This subfamily contains the genera Simplexvirus 
(HSV-1), Varicellovirus (VZV), Marek's disease-like virus, and Infectious laryngotracheitis-like 
virus.  
1.2.1.1 Genus Simplexvirus 
Simplexvirus is a spherical virion, enveloped (envelop contains viral glycoproteins, Fc 
receptors), 150-200 nm in diameter and double-stranded linear DNA genome of 124-235 kbp.   
Furthermore, it persist indefinitely in infected hosts Frequently reactivated in immunosuppressed 
hosts. 
The most known herpes viruses belonging to this genus are herpes simplex virus type 1 and type 
2.  Herpes simplex virus type 1 (HSV 1), taxon Human herpes virus 1 (HHV1) and herpes 
simplex virus type 2 (HSV 2), taxon human herpes virus 2 (HHV2) are responsible for 
developing oral herpes (cold sores) and genital herpes infections (Davison, 2010).  HSV disease 
can cause mild illness, not visible in the majority of patients, but also sporadic, severe, and life-
threatening disease in infants, children, and adults (Roizman et al., 2007).   Human seems to be 
the main reservoir for transmission of these viruses to other humans, since no animal vectors for 
human HSV infections were identified yet.  Virus is transmitted from infected to susceptible 
individuals during close personal contact.  Primary HSV-1 infections usually occur in early ages 
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of childhood commonly seen on mouth and lips.  Most genital HSV Infections are usually 
associated with HSV-2 and are acquired through sexual contact (Josey et al., 1966; Parker and 
Banatvala, 1967; Josey et al., 1972; Deardourff et al., 1974).   
1.2.1.2 Genus Varicellovirus 
Varicella-zoster virus (VZV), human herpes virus 3 (HHV3) is the most common virus of genus 
Varicellovirus.  VZV is closely related to the herpes simplex viruses (HSV), sharing much 
genome homology.  VZV virions are spherical and 180–200 nm in diameter.  VZV causes 
Varicella, known as chickenpox, characterized by fever and vesicular rash commonly in 
childhood age (Sanfillipo et al., 2004).  It has high tropism for T lymphocytes, which aids in 
viral dissemination to skin.  Like other herpes viruses, VZV causes latency in cells of the dorsal 
root ganglia.  Later in life, a latent infection of VZV causes herpes zoster, commonly known as 
shingles.  Shingles is known to affect adults and immunocompromised patients of all ages and 
causes acute pain, accompanied by severe fever (Mocarski et al., 2007). 
1.2.2 Betaherpesvirinae 
Betaherpesviruses are characterized by their capacity to infect restricted host range, with long 
reproductive cycle, causing the enlargement of the infected cells. The virus can be maintained in 
latent form in secretory glands, lymphoreticular cells, kidneys, and other tissues.  This subfamily 
contains the genera Cytomegalovirus (HCMV), Muromegalovirus (murine cytomegalovirus), and 
Roseolovirus (HHV-7).  Human cytomegalovirus (HCMV), taxon human herpes virus 5 (HHV5) 
belongs to the Cytomegalovirus genus and is the virus of interest in this work, see 1.3 below.  
1.2.3 Gammaherpesvirinae 
This subfamily contains two genera: Lymphocryptovirus and Rhadinovirus.  The host range of 
the members of the subfamily is limited to the family or order to which the natural host belongs.   
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In vitro, all members replicate in lymphoblastoid cells, and may also cause lytic infections in 
some types of epithelioid and fibroblastic cells.  Viruses in this group are usually specific for 
either T or B lymphocytes.   Latent virus is frequently demonstrated in lymphoid tissue. 
Epstein-Barr virus (EBV); human herpes virus 4 (HHV4) is the main representative 
Lymphocryptovirus genus.  EBV is widely spread in the human population with about 90% of 
persons being seropositive IgG for the viral capsid antigen (VCA) complex (Henle et al., 1969).  
It is transmitted via oral route.  Most children from 1-3 years become infected from other family 
members (Gratama et al., 1990).  Primary infections are normally asymptomatic, however it may 
cause mild to severe infectious mononucleosis (IM), when it occurs after 10 years of age 
(Crawford et al., 2006).  EBV is mainly associated with nasopharyngeal cancer, Burkitt’s 
lymphoma (tumor of the jaw and face found in children), and oral hairy leukoplakia (Khanna et 
al., 1995; Al-Kuraya  et al., 2006). 
 
Kaposi's Sarcoma-associated herpesvirus (KSHV); human herpes virus 8 (HHV8) is the main 
representative of the Rhadinovirus genus.  Initially, it was first suggested that HIV virus was 
causing KSHVcancer legions, as it was mainly found in HIV patients (Beral et al., 1999).  Later, 
KSHV was identifies to infect the endothelium originating cells known as spindle cells (Boshoff 
et al., 1995; Staskus et al., 1997; Sturzl et al., 1997), which then produce proinflammatory and 
angiogenic products (Ensoli et al., 1989).  KSHV is known to cause primary effusion 
lymphoma and some types of multicentric Castleman's diseas. 
1.3 Human cytomegalovirus 
1.3.1 Structure of human cytomegalovirus 
The virion of HCMV consists of an icosahedral capsid encasing a 235-kbp linear genome, 
surrounded by a tegument or matrix (Wright et al., 1964; McGavran and Smith, 1965) and 
enveloped in a lipid bilayer carrying a large number of virus-encoded glycoprotein’s (Spaete et 
al., 1994; Britt, 1996).   By cryoelectron microscopy, the capsid appears similar to, though larger 
than, the herpes simplex virus (HSV)-1 capsid (Chen et al., 1999).  HCMV has a double-stranded 
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DNA genome (Richard et al., 1985), capable of encoding more than 200 potential protein 
products (Hay et al., 1991).  A cartoon of the virus particle is shown in figure 1.1  
HCMV infected cells generate three different types of particles including: 
A- Infectious mature virions. 
B- Non infectious enveloped particles (NIEPs), composed of the viral proteins but lack viral 
DNA. 
C- Dense bodies, which are unique characteristic of HCMV infection and are non-
replicating, fusion-component enveloped particles, composed mainly of the tegument 
protein pp65. 
 
 
 
Figure 1.1: A graph of HCMV structure (from. http://viralzone.expasy.org). 
1.3.2 Glycoproteins of HCMV 
The viral glycoproteins are embedded in the lipid bilayer of the HCMV viral envelope.  The 
acquisition of the envelope and its associated glycoproteins occurs at both nuclear and cytoplasm 
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sites. The host antibody-mediated immune clearance mechanisms target the envelope 
glycoproteins (Mocarski, 2007; Britt and Mach, 1996).  There are approximately eight major 
glycoprotein types in the HCMV envelope. 
gB; pUL55 is the major envelope component and the most highly conserved glycoprotein in 
mammalian and avian herpes viruses.  gB is a type I integral membrane protein that functions   in  
viral attachment and entry into cells, cell-to-cell transmission, fusion to adjacent cells, and in 
targeting of progeny virus to apical membranes for release from polarized cells (Bold  et al., 
1996; Compton  et al., 1993; Navarro  et al., 1993; Tugizov et al., 1996;  Tugizov et al., 1998;  
Vanarsdall et al., 2008).  Cell surface heparan sulfate proteoglycans (HSPGs) is the major 
receptor for gB (Adlish et al., 1990; Taylor and Cooper, 1990).  
The HCMV UL16 gene encodes a glycoprotein which interferes with the immune response to 
virus-infected cell.  UL16 expression has been shown to promote intracellular accumulation of 
MICB, ULBP1 (Valés-Gómez et al., 2005). 
Several additional viral glycoproteins are likely to be minor envelope constituents but are not 
apparently associated with any major glycoprotein complexes.  HCMV gH, or gpUL75, is part of 
a second, relatively abundant glycoprotein complex to which neutralizing antibodies may be 
directed (Rasmussen et al., 1984).  gH complexes with at least one other herpesvirus-common 
glycoprotein, denoted gL, which facilitates the transport of gH to the cell surface (Kaye et al., 
1992; Spaete et al., 1993).  Finally, gL, encoded by UL115, is a glycoprotein modified by N-
linked and possibly O-linked carbohydrates.  Cell-cell fusion frequently involved in the majority 
of cells and gB and gH/gL were both necessary and sufficient for fusion, whereas no fusion 
occurred when either glycoprotein was omitted (Vanarsdall et al., 2008). 
1.3.3 Tegument proteins 
The tegument appears to be a relatively amorphous virion region located between the capsid and 
envelope.  The virion tegument contains most of the virion proteins as well as a selection of viral 
and cellular RNA making up about 40% of the total virion mass as well as the overwhelming 
majority of the dense body mass (Mocarski et al., 2007). 
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There are at least 25 proteins located in the tegument layer between the virion capsid and 
envelope.  These proteins are the  products of 11open read frames ( ORFs) (UL25, UL26, UL32, 
UL47, UL48, UL48.5, UL82, UL83, UL85, UL88, UL99).  All of These ORFs are conserved in 
the betaherpesviruses (Gompels et al., 1995; Nicholas, 1996; Rawlinson et al., 1996; Vink et al., 
2000), although only a small number is herpesvirus-common.   
1.3.3.1 pp65  
PP65 is the major tegument protein, and it is the target antigen used for rapid diagnosis of 
HCMV clinical infection by antigenemia assays.  The large amount of pp65 produced by 
laboratory strains of virus is associated with abundant dense body production.  Although all 
tegument proteins are phosphorylated, pp65 is a major phosphate acceptor in infected cells as 
well as a primary target for phosphorylation in vitro by the virion-associated protein kinase 
(Somogyi et al., 1990).   The formation of tegument aggregates appear to be dependent on pp65 
since they were not induced in cells infected with a pp65 deletion mutant (Prichard et al., 2005). 
1.3.3.2 UL97 kinase 
UL97 is a protein kinase encoded by (HCMV) is an important target for antiviral drugs (Kamil 
and Coen , 2007).  UL97 has a multi-step role in both early and late phases of the viral life cycle, 
namely DNA replication, capsid maturation and nuclear egress (Azzeh et al., 2006).  The 
absence of UL97 kinase activity results in a modified subcellular distribution of the viral 
structural protein assembly sites, from compact structures impacting upon the nucleus in the wild 
type to diffuse perinuclear structures punctuated by large vacuoles in ΔUL97 virus (Azzeh et al., 
2006).  UL97 protein was shown to have activities similar to cellular cyclin-cyclin-dependent 
kinase (CDK) complexes. UL97 phosphorylates and inactivates retinoblastoma tumor 
suppressor, stimulated cell cycle progression in mammalian cells, and rescued proliferation of 
Saccharomyces cerevisiae lacking CDK activity.  UL97 represents a functional ortholog of 
cellular CDKs that is independent of normal CDK control mechanisms (Hume et al., 2008).  
UL97 kinase plays an important role in the acquisition of tegument during virion morphogenesis 
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in the nucleus and this activity represents an important step in the production of mature virus 
particles (Prichard et al., 2005).  
UL97 phosphorylates the viral proteins UL44 (a DNA polymerase accessory protein (Krosky et 
al., 2003a, b ), and pUL69 (a tegument protein and pluripotent regulator) (Thomas et al., 2009) 
as well as the cellular proteins like p32 (Marschall et al., 2005), which facilitates viral infection. 
UL97-deleted HCMV are severely impaired in their replication, which may be the result of 
defects in viral DNA synthesis and particularly in nuclear export of viral capsids (Krosky et al., 
2003a, b). 
1.3.3.3 pp28 (ppUL99)  
PP28 is a 190-amino-acid tegument protein encoded by the UL99 open reading frame, which is 
myristoylated and phosphorylated (Sanchez et al., 2002a).  PP28 is essential for assembly of the 
infectious virus.  Nonenveloped virions accumulate in the cytoplasm of cells infected with 
recombinant viruses with a UL99 deletion.  pp28 is localized to the endoplasmic reticulum-Golgi 
intermediate compartment (ERGIC) in transfected cells, while in infected cells, it is localized 
together with other virion proteins in a juxtanuclear compartment termed the assembly 
compartment (AC)  (Sanchez et al., 2002b; Azzeh et al., 2006; Seo and Britt, 2006). 
1.3.3.4 pp150 (ppUL32) 
The major tegument phosphoprotein, pp150 (ppUL32 or basic phosphoprotein), is the product of 
UL32 (Jahn et al., 1987).  It is incorporated preferentially into virions rather than dense bodies, 
and it makes up about 20% of the virion mass (Benko et al., 1988). 
1.3.4 Capsid 
These viruses have a doughnut shaped capsomere about 100-200 nm in diameter with an 
icosahedral nucleocapsid.   The latter contains 162 capsomeres. 
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The capsid is composed of seven proteins: Major capsid protein (MCP) which is encoded by 
UL86 and forms both hexons and pentons, minor capsid protein (mCP) encoded by UL85, minor 
capsid binding protein (mC-BP) encoded by UL46, smallest capsid protein (SCP) encoded by 
UL48.5 (also called UL48/49), and three distinct assemblin/assembly protein (AP)-related 
proteins encoded by UL80,UL80a, and UL80.5 associate with capsids (Gibson, 1996; Gibson et 
al., 1996; Baldick and Shenk, 1996; Chen, et al., 1999; and Trus, et al., 1999).  The 
assemblin/assembly play major roles as scaffolding proteins, which have critical roles in capsid 
assembly.  The primary scaffolding components of cytomegalovirus, is the assembly protein 
precursor (pAP, pUL80.5) and the maturational protease precursor (pPR, pUL80a), both  
contains two nuclear localization sequences (NLS1 and NLS2),where at least one seems  
required to translocate the major capsid protein (MCP, pUL85) into the nucleus (Nguyen et al., 
2008). 
 
1.4 Life cycle of HCMV 
The HCMV life cycle begins with the attachment of the virus to the cell surface.  Initially, 
HCMV binds to cell surface heparin sulfate proteoglycans (HSPGs) as mediated via two viral 
envelope glycoproteins; major glycoprotein (gB) and glycoprotein M (gM) (Kari and Gehrz, 
1992; Compton et al., 1993).  HSPGs are not sufficient to stabilize the interaction; therefore, 
cellular epidermal growth factor receptor (EGFR) was suggested to be responsible for the stable 
interaction (Wang et al., 2003; Wang et al. 2005).  However, recent studies suggest that the 
HCMV binding event involves viral glycoproteins including gB interacting with β1 and β3 
heterodimers without the involvement of EGFR (Isaacson et al., 2007; Feire et al., 2010).  After 
binding to the cell surface, the virus penetrates the host cell membrane after fusing with it using 
the virion envelope by a process not fully understood which involves the gH/gL complex of 
glycoproteins expressed on the surface of the virus (Keay and Baldwin 1991; Milne et al., 1998).  
This fusion event results in the release of the nucleocapsid into the cytoplasm where it is quickly 
transported to the nucleus through intact microtubule networks utilizing a process that also 
requires actin depolymerization (Jones et al., 1986; Ogawa-Goto, 2003; Wang et al., 2005).  The 
nucleocapsid then transfers the viral DNA genome into the nucleus by a not fully understood 
mechanism (Wang et al., 2005).  
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Viral DNA expression in the nucleus begins with immediate early (IE), or α genes, which are 
expressed with the assistance of tegument proteins.  The viral life cycle takes approximately 
seventy two hours, hereby genes are referred to time point of their expression during this long 
life cycle (Salvant et al., 1998).  Immediate early genes are those expressed at early stages like 
IE1, IE2 are referred to as.  Delayed early genes are expressed within the first 48 h of infection, 
like the tegument protein pp65.  Late and true late genes are those expressed at late stages of 
infection, like the tegument protein pp28.  Most early gene products function to replicate viral 
DNA and their expression depends on the expression of IE gene products.  Viral DNA 
replication results in the generation of long concatemeric DNA molecules, which provide the 
templates for late (L) or γ gene expression (Salvant et al., 1998).  Virion structural components, 
virus assembly and egress genes are the products of L genes (Mocarski et al., 2007).  Late gene 
expression occurs once the virus begins replicating its genome and these genes encode for 
structural components of the virion.  Nucleocapsid particles are assembled within the nucleus 
and then acquire their tegument and envelope by yet undefined pathway.  The mature virus buds 
off from the cell into the surrounding area and can infect other permissive cells. 
At latent stage, HCMV does not produce infectious virus and can last for the life of the host.  
The immune system is unable to clear latent infection.  At reactivation stage, the virus switches 
from latent state back to a productive infection state (Mocarski et al., 2007), shedding of virus in 
saliva, urine or other body secretions. CMV DNA is typically detected in 2% to 5% of the 
population in saliva (Miller et al., 2005) or urine (Mehta et al., 2000) and, therefore, virus must 
either reside in these sites or be sporadically reseeded from a latent reservoir.  Reactivation from 
latency causes most of the serious CMV disease in immunocompromised individuals such as 
transplant recipients.   
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Figure 1.2: Summary of the HCMV life cycle (Crough and Khanna, 2009).  The viral entry 
begins as an attachment to the plasma membrane via viral glycoprotein and cell surface 
receptors, which facilitates the releasing of nucleocapsids to the cytoplasm, which is then 
translocated to the nucleus initiating viral DNA replication followed by capsid assembly and 
integration of the DNA in the capsid (Encapsidation).  This capsid buds from the nucleus as the 
virus gets the primary envelopment. Once transported to the cytoplasm, the virus undergoes 
secondary envelopment in the endoplasmic reticulum (ER)-Golgi intermediate compartment. 
Final envelopment occurs as a complex two-stage process, which is followed by exocytosis 
(virion release). 
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1.4.1 HCMV egress and assembly  
Following HCMV DNA synthesis, encapsidation proteins recognize this concatemeric template.  
Capsid localization, packaging, and cleavage of viral DNA are regulated by the conserved viral 
protein kinase, pUL97 as well as by cellular kinases, which may carry out redundant functions 
(Mocarski et al., 2007).  Upon the formation of the nucleocapsid, a complex two-stage 
envelopment and egress process starts in the nucleus and leads to virion release by exocytosis at 
the plasma membrane (Mettenleiter, 2004; Britt, 1996). This is a two-stage 
envelopment/deenvelopment/re-envelopment process (Sanchez and Spector, 2002; Mocarski et 
al., 2007).  Here, nuclear egress starts with primary envelopment at the inner nuclear membrane, 
followed by a de-envelopment event at the outer nuclear membrane and release of the 
nucleocapsid into the cytoplasm (Mocarski et al., 2007).  Secondary envelopment occurs in the 
cytoplasm at ER-Golgi intermediate compartment (ERGIC) membranes building a cytoplasmic 
assembly complex (AC).   
The cytoplasmic assembly complex (AC) in HCMV-infected cells is a juxtanuclear structure 
adjacent to the concave invaginations of the kidney shaped nucleus (Azzeh et al., 2006).  The 
morphology of AC depends on pUL97; it is compact “bulb” -like in wt-HCMV, but diffuse, 
“crown” -like and rich in vacuoles in the absence of pUL97 (Azzeh et al., 2006).  Inhibition of 
UL97 kinase activity using Maribavir or indolocarbazole NGIC-1 resulted also in the diffuse, 
“crown” -like and rich in vacuoles AC structure (Prichard et al., 2005; Azzeh et al., 2006).  The 
AC consists of viral tegument and glycoproteins (Sanchez et al., 2000a ; Prichard et al., 2005; 
Azzeh et al., 2006) and cytoskeletal filaments, which radiate from a microtubule organizing 
center into the AC (Sanchez et al., 2000a;  Das and Pellett, 2007). Markers of the Golgi 
apparatus, trans-Golgi network and early endosomes co-localize to the AC (Sanchez et al., 
2000a; Sanchez et al., 2000b; Homman-Loudiyi et al., 2003; Azzeh et al., 2006; Das and Pellett, 
2007).  The pUL97 is considered to play a role in phosphorylation of tegument proteins to 
facilitate their incorporation into virions, yet the molecular mode of interaction of the different 
components remains undefined. 
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1.5 Diseases caused by HCMV 
Congenital cytomegalovirus (CMV) infection is the most common and the most important of all 
congenital infection (Murphsu et al., 1998).  Hereby, the maternal immune status plays the major 
role in likelihood of congenital infection and the extent of disease in the newborn.  If primary 
maternal infection occurs during pregnancy, vertical transmission of HCMV is 15-20% higher 
than recurrent infection (Revello and Gerna, 2002). Most infants that have a congenital 
cytomegalovirus infection are born to women with recurrent HCMV infection.  Although most of 
these infants are clinically healthy at birth, they may have subtle growth retardation and are at 
risk for neurodevelopmental sequelae (Fowler et al., 1996). The major consequence of congenital 
cytomegalovirus infection is sensorineural hearing loss.  Approximately 15% of these infants 
will have unilateral or bilateral deafness due to the fact that this deficit may develop after months 
or even years after birth (Fowler et al., 1999).   
Cytomegalic inclusion disease (CID) is the most severe case of congenital CMV infection and 
comprises approximately 10% of infants with congenital infections with clinical evidence at birth 
CID is the result of primary HCMV infection.  
Perinatal acquisition of cytomegalovirus usually occurs via infected secretions of HCMV in the 
birth canal or via breastfeeding (Mocarski et al., 2007).  Maternal breast milk should be 
subjected to viral shedding detection, when babies suffer from low birth weight (Schleiss et al., 
2006).   
Typical cytomegalovirus mononucleosis is a disease found in young adults (Henle et al., 1969) 
which leads to fever and severe malaise, an atypical lymphocytosis and mild elevation of liver 
enzymes.  Although cytomegalovirus mononucleosis may be transmitted via blood transfusion or 
organ transplantation, cytomegalovirus mononucleosis is usually acquired via person-to-person 
transmission (Akhter et al., 2012)   
Immunocompromised patients have high risk of getting infected by cytomegalovirus. HCMV 
infection in these patients can be an acquired via transfusion or organ transplant from a 
seropositive donor or by reactivation of latent virus infection.  Mixed Infections may arise, with 
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donor and recipient isolates both present (Revello and Gerna, 2002).  The most important clinical 
manifestations consist of pneumonitis, GI disease, and retinitis. 
Human Cytomegalovirus pneumonitis is a major cause of pneumonitis in immunocompromised 
patients such as in HIV infection, congenital immunodeficiency, malignancy, and solid organ or 
bone marrow transplant (Schleiss et al., 2006).  The mortality rate is high in bone marrow 
transplant recipients (Schleiss et al., 2008).  Cytomegalovirus is capable of causing a multiple GI 
tract diseases which include esophagitis, gastritis, gastroenteritis, pyloric obstruction, hepatitis, 
pancreatitis, colitis, and cholecystitis.  The symptoms may that include nausea, vomiting, 
dysphasia, epigastria pain, icterus, and watery diarrhea. 
Cytomegalovirus retinitis was the most common cause of blindness in adult patients with 
acquired immunodeficiency syndrome (AIDS). 
1.6 HCMV antiviral drugs 
Nucleoside analogues aciclovir, adefovir, cidofovir, ganciclovir, penciclovir and valaciclovir, 
and the pyrophosphate analogue foscarnet are the antiviral agents currently approved by the FDA 
for treatment of CMV (Mocarski et al., 2007).  These drugs reduce or eliminate viremia or 
HCMV shedding and prevent or control CMV disease in specific situations in 
immunocompromised patients.  A potential for significant toxicity is possible during treatment, 
therefore, use should be limited to patients with disabling or life-threatening disease (Eddleston 
et al., 1997).  Antiviral treatment of severe congenital HCMV infection with ganciclovir is based 
on evidence that it prevents late onset or progressive hearing loss (Mocarski et al., 2007).  
Valganciclovir (Valcyte) is an antiviral drug that is also effective and is given orally (Borthwick, 
2005).   
The therapeutic effectiveness of these drugs is frequently compromised by the emergence of 
drug-resistant virus isolates.  A variety of amino acid changes in the UL97 protein kinase and the 
viral DNA polymerase have been reported to cause drug resistance.  Therefore, Foscarnet or 
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cidofovir are only given to patients with CMV resistant to ganciclovir, because foscarnet may 
cause nephrotoxicity (Borthwick, 2005).   
Cytomegalovirus Immunoglobulin Intravenous (Human) (CMV-IGIV) is an immunoglobulin G 
(IgG) containing a standardized amount of antibody to Cytomegalovirus which may reduce the 
risk of CMV-related disease and death in some of the highest-risk transplant patients (Scott et al., 
2006).  Maribavir, a benzimidazole L-riboside, a promissing antiviral compound was a in clinical 
development (Lu and Sun, 2004) and was shown to inhibit both UL97 kinase and viral DNA 
synthesis (Evers et al., 2004; Krosky et al., 2003).  Maribavir has undergone phase I and II 
clinical trials and phase III prophylaxis trials in solid organ and stem cell transplant recipients 
(Lu and Sun, 2004; Winston et al., 2008).  In February 2009, ViroPharma announced that Phase 
III study failed, as no significant difference between maribavir and a placebo in reducing the rate 
at which CMV DNA levels were detected in patients (www.viropharma.com/) 
To date all Anti HCMV drugs targeted the viral DNA polymerase which have high toxicity. 
Once resistance emerges, treatment chances are very narrow.  A very recent promising drug, 
AIC246, was introduced recently by AiCuris company (AiCuris GMBH, Germany) is currently 
in clinical phase II.  AIC246 has a different mode of action – targeting viral terminase complex – 
and was tested successfully in HCMV infected patients and specifically in those infected with 
ganciclovir resistant strains (Lischka et al., 2011; Goldner et al., 2011; Kaul et al., 2011). 
1.7 Epidemiology of Human CMV Infection 
Seroepidemiologic studies show that HCMV is universally distributed among human populations 
from developed, industrial societies to isolated aboriginal groups (Ahn, et al., 1997; Heise, et al., 
1998).  In general, HCMV seroprevalence is high and acquired earlier in life in developing 
countries and in the lower socioeconomic strata of developed countries (Mocarski et al., 2007).  
Studies that have included both sexes consistently report slightly higher prevalence rates in 
women than in men (Demmler et al., 1985; Balcarek et al., 1990; Hecker et al., 2004).  The 
prevalence of HCMV was reported to be 95%-99% in Turkey (Hizel et al., 1995), in Benin 
(Rodier et al., 1995), in South Korea (Sohn et al., 1992) and Japan (Hirota et al., 1992) compared 
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to lower prevalence (50%-70%) in Europe and the USA (Stagno et al., 1986; Natali et al., 1997; 
4076, Gratacap-Cavallier et al., 1998).   
Although HCMV is predictably transmitted in settings where susceptible people have frequent 
contact with body fluids from persons excreting virus, HCMV is not highly contagious and 
transmission appears to require direct contact with infectious material (Mocarski et al., 2007).  
Following initial acquisition of HCMV, infectious virus is present in urine, saliva, tears, semen, 
and cervical secretions for months to years.  High rates of HCMV infection occur in settings 
where close contact with body fluids is expected, such as between sex partners (Chandler et al., 
1985; Stanberry et al., 2004), among children in day care centers, and between preschool-aged 
children (Pass et al., 1984; Murph et al.,1986; Adler, 1988).   
 
1.8 ER stress 
The endoplasmic reticulum (ER) is a central organelle of each eukaryotic cell as the place of 
lipid synthesis, protein folding and protein maturation.  Proteins of the plasma membrane, 
secreted proteins as well as proteins of the Golgi apparatus and lysosomes fold into their tertiary 
and quaternary structure in the ER.  The ER is the major signal transducing organelle that senses 
and responds to changes of homeostasis.  A quality control mechanism exists in the ER to ensure 
the success of proteins processing in the ER.  Proteins which have been improperly folded or 
modified are selected.   The accumulation of misfolded proteins causes ER stress.  ER stress 
leads to activation of a complex signal transduction cascade; the unfolded protein response 
(UPR) (Harding et al., 2001).  Metabolic conditions (e.g., glucose deprivation) and infection by 
viruses are physiological conditions which induce ER stress and UPR cascade (Li et al., 1992; 
Tardif et al., 2002). 
Activation of the UPR  to eliminate misfolded proteins in the ER can occur by two ways:  
1- Upregulating the expression of chaperone proteins and degradation factors to refold or 
eliminate misfolded proteins (Rutkowski and Kaufman, 2004)  
2- Attenuating translation to reduce incoming protein traffic in the ER (Rutkowski and 
Kaufman, 2004) 
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Different cellular genes are upregulated to participate in the cell recovery from ER stress.  
Nevertheless, if the cell fails to recover from ER stress, it undergoes apoptosis. 
 
1.8.1 ER stress and viruses 
In order for viruses to maintain cellular infection, a high demand on cellular nutrients must be 
available (Alwine, 2008).  An increase in glucose uptake and manipulation of the cell cycle are 
essential  to grant the virus its optimal infection are essential (Alwine, 2008).  Above all, the 
virus have to control cell apoptosis to complete its infection cycle successfully (Alwine, 2008).  
Cellular responses signal the cell when potential danger exists to initiate conditions to survive 
stress, otherwise cells undergo apoptosis.  
Viral replication elicits cellular responses, such as endoplasmic reticulum (ER) stress.  It is, 
therefore, not surprising that viruses have evolved various mechanisms to cope with these 
responses that limit or inhibit viral replication (Alwine, 2008). 
 
1.8.2 ER stress and HCMV 
Human cytomegalovirus (HCMV) infection induces cellular stress responses due to nutrient 
depletion, energy depletion, hypoxia and synthetic stress, e.g., endoplasmic reticulum (ER) 
stress.  Cellular stress responses initiate processes that allow the cell to survive the stress, where 
some of these responses may be beneficial to HCMV replication while others are not.  Several 
studies show that HCMV manipulates stress response signaling in order to maintain beneficial 
effects while inhibiting detrimental effects (Isler et al., 2005b; Hakki et al., 2006).  Since 
inhibition of translation as a result of ER stress would be harmful to HCMV infection, HCMV 
has to find ways to maintain the cell in the metabolically and translationally active state until the 
end of its replication cycle.  Different studies have illuminated certain mechanisms, by which 
HCMV overcomes the harmful effects of ER stress to mainatain its life cycle and cellular 
translation (Child et al. 2004; Kudchodkar et al. 2004; Hakki and Geballe 2005; Isler et al. 
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2005a, 2005b; Walsh et al. 2005; Hakki et al. 2006; Kudchodkar et al., 2006; Kudchodkar et al. 
2007).  HCMV pUL38 protein was shown to be required to maintain the viability of infected 
cells, through blocking cell death induced by Thapsigargin (Xuan et al., 2009).  In order to do so, 
UL38 induces ATF4 expression, that inhibits persistent JNK phosphorylation, and suppresses 
endoplasmic reticulum stress-induced cell death. 
 
1.9 ER stress drugs 
1.9.1 Thapsigargin 
The UPR can be induced using drugs such as tunicamycin, which inhibits N-linked glycosylation 
in the ER, and thapsigargin, which disrupts calcium homeostasis in the ER. 
Thapsigargin is a non-competitive inhibitor of a class of enzymes known by the acronym 
SERCA, which stands for sarco / endoplasmic reticulum Ca
2+
 ATPase.  Structurally, 
thapsigargin (TH) is classified as a sesquiterpene lactone, extracted from a plant; Thapsia 
garganica.  Thapsigargin raises cytosolic calcium concentration by blocking the ability of the 
cell to pump calcium into the sarcoplasmic and endoplasmic reticula which causes these stores to 
become depleted. Store-depletion can secondarily activate plasma membrane calcium channels, 
allowing an influx of calcium into the cytosol (Begum et al., 1993). 
TH is useful in experimentation examining the impacts of increasing cytosolic calcium 
concentrations.  TH is an effective inhibitor of the Ca2+ ion pump proteins of intracellular 
membranes located in sarcoplasmic reticulum (SR) and endoplasmic reticulum (ER) of skeletal 
muscles, cardiac muscles and brainmicrosomes.  TH reduced insulin-stimulated glucose transport 
by about 40% by (Begum et al., 1993) and Protein synthesis in cells was inhibited (Wong et al., 
1993). 
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1.10 Project significance 
HCMV has a slow life cycle, which demands the interaction of various cellular and viral gene 
products. The virus has only one single kinase of it own, which should guarantee the 
phosphorylation of different cellular and viral proteins achieving different targets in the viral 
replication cycle including maintaining cell activities to avoid apoptosis.  This work focuses on 
studying one aspect of the viral life cycle in respect to cellular ER stress, namely viral assembly 
complex.  Viral assembly complex (AC) is the site, where variable viral proteins are assembled 
to start the journey of building progeny viruses.  Once the virus assembly complex is built and 
maintained, successful infectious progeny virions can be produced.   
Our work investigates the influence of ER stress on HCMV assembly complex by studying 
different viral and cellular proteins involved in building and maintaining the assembly complex.  
The results shed some light on unknown viral proteins involved in modulating ER stress for the 
benefit of the virus.    
1.11 Objectives 
1- Investigate the HCMV assembly site and its biological properties by "in vitro" activation 
of cellular ER stress 
2- Detect the influence of induced ER stress on HCMV viral replication 
3- Study the mechanism, by which ER stress affects the assembly site 
4- Determine the time point, at which ER stress affects the viral replication generally 
5- Illuminate viral proteins involved in modulating ER stress 
02 
 
 
 
 
 
 
Chapter Tow  
2. Materials and Methods 
2.1. Culturing of Cells  
Human foreskin fibroblasts (HFF) (kindly provided by Dr. Nina Mayorek, Hebrew University) is 
a primary cell line isolated from newborn male’s foreskin.  The 293T cells (kindly provided by 
Prof. Chakraborty, University of Giessen, Germany) are Human embryonic kidney cells, that 
have been transformed by exposing cells to sheared fragments of adenovirus type 5 DNA and 
contain the SV40 large T-antigen that allows episomal replication of transfected plasmids 
containing the SV40 origin of replication (Graham and Smiley, 1977).  HFF and 293T cells were 
cultured in flasks (Easy Flask, 25 cm
2
, 75 cm
2
, 175 cm
2
, Nunc, Denmark) or well plates in 
complete DMEM medium (DMEM; 01-055-1A, Beit Haemek, 1:1000 dilution of Pen/Strep; 03-
031-5C, Beit Haemek, 20 mM L-Glutamine; 03-020-1A, Beit Haemek and 10%  heat inactivated 
serum; 1:1 mixture of New born bovine serum, 04-121-1A and Fetal bovine serum, 04-122-1A, 
Beit Haemek).  The amount of complete DMEM medium added to the cells for culturing 
depends on the type of cell culture unit used as mentioned in Table 2.1.  Cells were cultivated in 
96% humid CO2 incubator (5% CO2) at 37°C (Hera cell incubator).  The 293T cells were mainly 
used for transfection assays (see 2.12).  All cell culture work was performed in laminar flow 
purifier safety cabinet (purifier class II biosafety cabinet, Labconco, USA).   
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2.1.1 Propagation and Passage Cells  
Passaging (also known as subculture or splitting cells) involves transferring a small number of 
cells into a new vessel.  Cells can be cultured for a longer time if they are split regularly.  For 
this, cells need to be detached; commonly made with a mixture of trypsin-EDTA.  Cells were 
propagated by splitting into two or more culture flasks, or into different well plates, using 0.25% 
Trypsin-EDTA (03-052-1A, Beit Haemek) was added to the confluent cells in flask for 1-2 
minutes.  Cells were loosened by gently up and down pipetting using sterile disposable plastic 
pipettes.  Complete medium was added to the non adhering trypsinized cells, gentle mixed and 
distributed to the new flasks.  The new cells are one passage higher than the one they were split 
from.  Since HFF is a primary cell line, it was propagated up to passage 18 in our lab.  
Experiments were performed on passages 10-18, while the passage number for 293T cells was 
unknown. 
 
2.1.2 Freezing and Thawing of HF Cell   
Cells can be kept for years if frozen in liquid nitrogen.  HFF cells were frozen at low passages 
(6-12).  Freezing proceeded as follows for a medium flask (75cm
2
): 
1. Cells were trypsinized as above  
2.  Cells were collected by centrifugation at 1500 rpm for 10 minutes.  
3.  Supernatant was discarded and pellet was re-suspended in (50% complete medium, 40% 
serum, 10% DMSO, dimethylsulphoxide, Sigma-Aldrich, Germany).  
4. Suspension was transferred into sterile labeled freezing cryotube (cat#363401, Nunc, 
Denmark)  
 5.  Cells were frozen overnight at -80˚C, then transferred to the liquid nitrogen container 
 
Thawing Cells:  
1.  Cryotube containing the required cells was removed from the liquid nitrogen container to 
room temperature 
2. Thawn cells were directly transferred to a small flask containing 4ml DMEM complete 
medium and mixed 
00 
 
3. Flask was transferred to the 96% humid CO2 incubator 
 
2.2 Viruses 
In this work, HCMV viral strains, either as wild type (wt) or deletion mutant, were used.  HCMV 
strain AD169 (wt-HCMV; American Type Culture Collection) and pp65 deletion mutant 
(Δpp65) were a kind gift from Prof. Bodo Plachter, University of Mainz-Germany.  The UL97 
deletion mutant, ΔUL97, was kindly provided by Dr. Mark Prichard (University of Alabama, 
USA).  All viruses’ related techniques were performed in laminar flow purifier safety cabinet 
(purifier class II biosafety cabinet, Labconco, USA).  
 
2.2.1 Propagation of Viruses 
HCMV is typically propagated in primary cultures of human fibroblasts that yield relatively high 
titer stocks and produce plaques when infected with HCMV.  
  
Infection assay  
1. Medium was discarded from HFF cells  
2. AD169, Δpp65 or ΔUL97 was added at an MOI of 0.05 PFU/ml (diluted in complete 
DMEM) with the minimal amount of medium volume to cover the cells, i.e. 4 ml for  a 175 
cm
2
 flask 
3. Infected cells were incubate in 96% humid CO2 for 2 h 
4. Inoculum was removed and replaced with complete DMEM medium 
 
Moi represents the number of viruses divided by the number of cells.  In this work viruses were 
propagated in 175 cm
2
 flasks, which contain 3x10
7
 HFF cells.  For this, 4 ml viral suspension 
(virus stock diluted in complete medium) at moi of 0.001 were added to the cells and incubated 
in 96% humid CO2 incubator (5% CO2) at 37°C.  At 10 days post infection (pi) viruses were 
harvested by collecting the 30 ml supernatant in a sterile 50 ml tube and replaced with fresh 30 
ml complete medium for further incubation to perform a second viral harvest.  Viral harvest was 
centrifuged for 10 min at 1500 rpm to get rid of cell debris; supernatant was transferred to a new 
02 
 
50 ml tube.  Finally, 1% DMSO was added to the viral supernatant and the mixture was 
aliquoted in cryotubes, and frozen at -70
o
C and in Liquid nitrogen.  At 14 days pi, the second 
viral harvest is performed as above and the highly infected cells were discarded. 
 
2.2.2 Viral Titration and Plaque Assay 
Plaque-based assays are the standard method used to determine virus concentration in terms of 
infectious dose.  Viral plaque assays determine the number of plaque forming units (pfu) in a 
virus sample, which is one measure of virus quantity in our works, based on a microbiological 
method conducted in petri dishes or multi-well plates.  A viral plaque is formed when a virus 
infects a cell within the fixed cell monolayer.  The virus infected cell will lyse and spread the 
infection to adjacent cells where the infection-to-lysis cycle is repeated. The infected cell area 
will create a plaque (an area of infection surrounded by uninfected cells) which can be seen 
visually or with an optical microscope. Plaque formation can take 14 days in the case of HCMV. 
In this regards, an aliquot of frozen viral harvest was thawed and viral dilutions of 10
-1
-10
-8
 
(titrations) were prepared step wise (1:10 dilution steps) in complete medium.  90% confluent 
HF cells cultured in 24 well plates (Nunc, Denmark) were infected with 0.1 ml of either the 
undiluted viral stock, or one of the 10
-1
-10
-8
 viral dilutions.  Four wells (one column) of the 24 
well plates were infected with the same viral dilution to guarantee 4 controls of each dilution.  
Infected 24 well plates were incubated in 96% humid CO2 incubator (5% CO2) at 37°C.   
During this incubation period, agarose was prepared.  Hereby, 2.5% agarose was dissolved in 
dH2O (distilled water) and kept at 50°C.  Complete DMEM was also pre-warmed up to 50°C.  A 
0.25% agarose was prepared in the pre-warmed complete medium at 2 h post infection.  At this 
time, media containing virus was removed from each of the infected well (one column in row) 
and replaced with 1 ml 0.25% agarose containing complete medium.  This procedure has to be 
done pretty fast to avoid polymerization of the agarose.  Plates were then left at room 
temperature (RT) for 30 min to allow agarose to polymerize and then transferred to the cell 
culture incubator (96% humid CO2 incubator (5% CO2) at 37°C).  One week later, another 1ml 
of agarose-containing DMEM complete medium is added following the procedure above. The 
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agarose in the medium should hinder virus progeny from spreading to neighboring cells and 
allows counting the plaques in the correct dilutions resulting from infection independently in 
different cell groups.  At 2 weeks pi, viral plaques were counted in wells with separate plaques.  
The viral titer, also referred to as plaque forming unit (pfu) was calculated as following: 
 
pfu/ml= 
#plaques/dxV 
 
 
 
 
d= dilution factor 
V = volume of diluted virus added to the well 
2.2.3 Viral infection assay 
In most experiments, HFF cells were infected with HCMV viral type at moi of 0.5.  Cells were 
counted after trypsinization using the Neubauer chamber.  The number of cells is important to 
determine the virus concentration to be used for a specific moi.  The volume of virus containing 
medium is important as the minimal amount should be used to allow viral infection of the cell.  
Table 2.1 summarizes the different growth medium and virus containing medium used for each 
different cell culture unit used in this work.    
 
Table 2.1: Amount of complete DMEM medium used in cell culture and infection experiments. 
Cell culture unit Growth 
medium (ml) 
virus containing 
medium (ml) 
175 cm
2
 (big flask) 20 4 
75 cm
2
 (medium flask) 10 2 
25 cm
2
 (small flask) 4 1 
6 well plate (per well) 3 1 
12 well plate (per well) 1 0.4 
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24 well plate (per well) 1 0.2 
Chamber slide (per well) 0.5 0.15 
  
 
The appropriate amount of virus was always diluted in complete medium to give the desired moi.  
Complete medium was warmed up to room temperature, while virus stock was used as soon as it 
was thawed.  The virus containing medium was always prepared directly before infection.  For 
infection, medium was removed from cells and virus containing medium at the specific moi was 
added instead.  In most cases infection lasted for 2h, when virus containing medium was 
removed and replaced with fresh medium or drug containing medium in drug inhibition assays 
(see 2.7).  The hours of post infection (hpi) varied depending on the experiment between 2 hpi 
and 96 hpi.  In mock infections, no virus was added at any time point of the experiment. 
 
2.3 Drug inhibition assay and Inducing ER stress 
To investigate the influence of ER stress on HCMV infected cells, BAPTA-AM (cat# 11696, 
Sigma-Aldrich, Germany) and Thapsigargin (cat# 9033, Sigma-Aldrich, Germany) were utilized.  
Stock solutions of both drugs were prepared in DMSO and therefore the same concentration of 
DMSO was used in drug control experiments.  Initially, these drugs were tittered before 
calibration experiments to identify the concentration, which does not harm the cells, but induce 
ER stress.  Starting with 2 µM, a concentration of 0.5 µM was found to be the optimal 
concentration, which was not toxic to the cells, but induced ER stress.   
Drugs were added to HFF cells pre-infection or at post infection with HCMV virus.  In the first 
case, cells were incubated for 30 minutes with medium containing either drug or DMSO control.  
Cells were then either infected or mock infected at moi of 0.5, 2 h later virus containing medium 
was removed and replaced with fresh medium.  In the second case, cells were either infected or 
mock infected at moi of 0.5, 2 h later virus containing medium was removed.  Cells were washed 
twice with complete medium before adding complete medium containing either the drug or 
DMSO control.  With the exception of kinetic experiments, the effect of ER stress was detected 
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at 96 hpi.    At 96hpi supernatant was frozen to perform plaque assay and viral load, while cells 
were subjected to IF (see 2.5) or western blot (WB, see 2.9).  Frozen supernatants of drug 
inhibition versus no inhibition were thawed and subjected to plaque assay and viral load analysis. 
 
2.4 Kinetic experiments 
These experiments were performed to detect the influence of ER stress inducer thapsigargin part 
during HCMV infection. Infection was performed as detailed in 2.2.3 or mock infected on 12 
well plates for immunofluorescence (IF) analysis and 6 well plates for protein analysis.   
Testing was performed every 2 hpi or in 24 hpi intervals (24 hpi, 48 hpi, 72 hpi and 96 hpi) and 
subjected to IF analysis, while 200 µl aliquoted supernatants at these exact time points were 
frozen at -70 ºC  and later subjected to viral load analysis.  For Western blot kinetic analysis, 
infected versus mock infected cells were lysed every 2 hpi or in 24 hpi intervals (24 hpi, 48 hpi, 
72 hpi and 96 hpi) and subjected to WB analysis as detailed in 2.9.  In some cases the drug was 
added before infection and then infected as in 2.2.3 and subjected to kinetic experiment. 
 
2.5 Immunofluorescence (IF)  
Immunofluorescence (IF) is widely used for the rapid diagnosis of virus infections by the 
detection of virus antigen in clinical specimens, as well as the detection of virus-specific IgG or 
IgA or IgM antibody.  Cells were grown directly on pre-sterilized coverslips (18 mm) in 12 well 
plates or on 8-well glass slides (Labtek chamber slid, cat#177402, Nalge Nunc International, 
Naperville, IL 60563).  The cells were infected at moi of 0.5, once cells were 90% confluent.  
Two hours after infection, virus containing complete DMEM was removed and replaced with 
virus free complete media for 96h (=96hpi).  At 96 hpi, cells were washed three times with 1X 
PBS (8g NaCl, 0.2g KCl, 1.44g Na2HPO4, 0.24g KH2PO4 in 1000 ml dH2O, pH 7.4) and fixed 
with 3.7% paraformaldehyde (diluted in PBS) for 30 min at RT, washed with PBS (3X), 
permeablized with 0.1% Triton X-100 (T8787, Sigma-Aldrich, diluted in PBS) for 1-2 min at 
RT.  After another was (5X with PBS), blocking with 1% bovine serum albumin (BSA, 0175, 
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AMRESCO Inc., USA, prepared in PBS) was performed. Blocking was performed for 30-60 
minutes or overnight at 4°C.  
 
First antibody was diluted in 0.5% BSA and incubated with cells for 2 hrs at RT or over night at 
4
o
C.  In case of co-localization experiments, the first two antibodies of the different antigens 
were pre-mixed before adding them to the cells.  After sucking out the antibody solution, cells 
were washed five times intensively and carefully.   
 
The secondary antibody was diluted at a proper concentration in 0.5% BSA and incubated with 
the cells 30-60 min in the dark by covering the plates with aluminum paper or by placing them in 
the dark. In case of co-localization experiments of IF, secondary antibodies were pre-mixed 
before adding them to the cells.  Before the last wash, the nucleus was stained with 1µg/ml 4′, 6-
diamidino-2-phenylindole, 2HCl (DAPI, 268298, Calbiochem, Germany) for 10 min at RT.  
Cells were washed 5 times with PBS.  Finally, Mounting medium was done to helps preserve 
your sample and raises the refractive index to give good performance with oil objectives. cells 
were covered with mounting anti-fading solution (0.5% g n-porpyl gallate; P3130, Sigma-
Aldrich, Germany; 100mM Tris pH 9 , 70% glycerol).   
 
In case of 8-well chamber slides, the wells were carefully peeled off, covered with a cover slip 
and gently pressed using kimwipes to get rid of excessive mounting solution.  The edges of both 
surfaces of the slide and cover slip were carefully glued with colorless nail polish.  In case of 
glasses in 12 well plates, glasses were inverted on objective slide, gently pressed using kimwipes 
to get rid of excessive mounting solution and carefully glued with colorless nail polish to the 
objective slide. 
 
 
2.6 Monoclonal, Polyclonal Antibodies and Fluorescing Markers 
Variable monoclonal and polyclonal antibodies used in this work were to perform either IF or 
Western blot (WB) experiments.   
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Primary mouse monoclonal antibodies (mAbs) against HCMV: pp28 (CA004-100), pp65 
(CA003-100), ICP22 Delayed Early Protein, against CMV ICP36 DNA Binding Protein , CMV 
gb-CH28, and glycoprotein B (gB, CA005-100) and IE1/IE2 (CH160) were purchased from 
Virusys Corporation (Sykesville, MD, USA).   
The cellular antibodies were mainly rabbit and polyclonal, so co-localization with viral 
antibodies can be performed.  GRP78 Bip (ab21685), beta-Actin-Loading control (ab8227) and 
eIf-2α (ab32157) were purchased from Abcam (Abcam, United Kingdom).  CREB-2 (C-20) was 
purchased from Santa Cruz Biotechnology inc. (USA).  Secondary antibodies, Goat anti Rabbit-
Cy2 (111-225-144), Goat anti Rabbit-Cy5 (111-175-144), Goat anti-Rabbit-HRP (111-035-003), 
Goat anti-Mouse-HRP, Donkey anti-Mouse-Cy2 (715-225-150), Donkey anti-Mouse-Cy5 (715-
175-150) were purchased from Jackson Immunoresearch (Jackson Immuno Research 
Laboratories, Inc., West Grove, PA, USA).  All secondary antibodies are highly cross-absorbed.  
Golgi marker Wheat germ agglutinin (WGA, L4895 coupled to fluorescein isothiocyanate 
(FITC) was obtained from Sigma (St Louis, Missouri, USA). 
 
2.7 Fluorescence Image capturing 
Visualizing immunofluorescence staining and capturing was done using an Olympus BX60 and 
Olympus digital camera DP71 (Olympus, Japan).  DAPI staining of the nucleus was visualized 
via U-MWU mirror, Cy2 via U-MWIB and Cy5 via U-MWIY2 (all Olympus mirrors, Olympus, 
Japan) respectively.  Image of each fluorescence color was captured in single mode using 
analySIS LS report program (Olympus, Japan).  In co-localization experiments, the same image 
was captured via the different mirrors in single mode and merged via Picture Merge Genius 
program (EasyTools Software, Inc., USA). 
 
2.7.1 Recording structures of subcellular distribution 
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Once, a change in nuclear shape or in subcellular distribution was detected via IF, a statistical 
analysis was performed, to decide, whether this change is statisticaly relevant or not. For this, 
structures were recorded in 10 fields of at least 100 cells from 3 different experiments.  
Alternatively, structures were recorded from captured images. 
 
2.8 Cell Lysis for protein extraction 
For lysis, DMEM was removed at 96 hpi or from mock infected cells and washed with ice cold 
PBS.  A minimum amount of cold PBS was used in the last wash, in which cells were scraped 
down into ice cold eppendorf tubes using sterile cell scraper (cat#70-1250, Biologix, KS, USA).  
Cells were down centrifuged for 10 minutes at 3000 rpm and 4ºC and re-suspended in ice cold 
cell lysis buffer.  Cell lysis buffer was partially freshly prepared prior to the experiment and kept 
on ice as explained below.  
Stock buffer for cell lysis (50mM Tris pH 7.4, 150mM NaCl, and 10% glycerol) was prepared, 
filtered and stored at 4ºC.  Just before use 0.5% NP40 was added as well as protein kinase 
inhibitor mix (Leupeptin, 1 µg/ml, L2884, Aprotinin, 2.5 µg/ml, A4529, PMSF, 1 mM, P7626 
and sodium vanadate, 1mM, S6508, Sigma-Aldrich, Germany).  The total amount of lysis buffer 
depended on the amount of cells; 0.5 ml for medium flask, 0.3 ml for small flask and 0.2 ml for 6 
well plate respectively.  After 30 minutes on ice with gently mixing in 10 minutes intervals, cell 
debris was down centrifuged for 10 minutes at 13000 rpm and 4ºC by.  Supernatant was kept in 
30 µl aliquots frozen at -70 ºC.   
 
2.9 Western Blot analysis (WB) 
2.9.1 Preparation of the polyacrylamide Gels 
BioRad vertical gel electrophoresis system was used (165-3302 Mini-PROTEAN 3 
Electrophoresis Module, BioRad, CA, USA).  We was used two types of gels to complete WB 
assay the first one was called staking gel which is must be used to be sure all the samples loaded 
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on the gel and run on the same line. But these gel must be prepared after the resolving gel was 
polymerized. 
5% stacking solution was prepared: 
- 1.4 ml dH2O 
- 0.33 ml 40 % PAA  
- 0.5 ml 1 M Tris (pH 6.8).  
- 0.02 ml 10% SDS 
- 0.02 ml 10% APS 
-  0.002 ml TEMED 
- 10% resolving gel for 2 gels:  
- 7.9 ml dH2O  
- 6.7 ml 40% Polyacrylamide (PAA, Beit Haemek) 
- 5 ml 1.5 M Tris pH 8.8. 
- 0.2 ml 10% SDS (in dH2O) 
- 0.2 ml 10% ammonium per sulfate (APS, prepared in dH2O and frozen until use) 
- 0.008 ml TEMED (N,N,N′,N′-Tetramethylethylenediamine, T9281, Sigma, Germany) 
 
Solution was loaded bubble free in BioRad casting system (165-3302 Mini-PROTEAN 3 
Electrophoresis Module, BioRad, CA, USA) using 1.5 mm comb. 
Once polymerized glass plates with gels and combs were casted in BioRad vertical casting 
system, SDS- Running buffer (25 mM Tris base, 220 mM Glycin, 0.1% SDS) was placed 
between the plates and outside them in the tank.  Combs were removed carefully and slots were 
inspected and polymerized gel pieces in the slots were removed if found. 
 
 
2.9.2 Sample Preparation 
1- 10 µl of 4x Lammli buffer (20mM Tris, pH 6.9, 4% SDS, 40% Glycerol, 0.004% Bromphenol 
blue+ freshly added 8.4% β-Mercaptoethanol) was added to the 30 µl of protein aliquot (see 2.5). 
2- Samples were denaturated at 95 °C for 10 min and kept on ice.  
22 
 
3- Samples were carefully loaded into slots along with 2 µl pre-stained protein marker (SM0441, 
Fermentas, Canada)  
4- Proteins were run at 80 V (constant Ampere) for 30 min initially, then at 130 V along with a 
protein ladder (SM1841, Fermentas). 
 
 
2.9.3 Blotting (Transfer) 
1- 8.5 X 6.5 cm PVDF membrane (1 per gel, BioTraceTMPVDF, Pall corporation, FL, USA) 
and 8.5 X 6.5 cm Whatmann paper (4 per gel, 580x580 mm thick Whatmann) were prepared 
2- PVDF membrane was activated: 5 min incubation in methanol followed by washing in dH2O 
and finally well covered in transfer buffer (3g Tris base, 14.4g Glycin, 800ml dH2O and 200 ml 
Methanol).  Whatmann paper was also well covered with transfer buffer 
3- Stacking gel was separated from Resolving gel by cutting 
4- Blot sandwich was prepared as following  
 2whatmann            Membrane            Gel             2whatmann 
 
5- Blotting for 1hr, at 25V, constant Ampere in semi dry blotter (this may be subjected to change 
based on the size of the protein)   
6- 1%  dry skim milk (Fluka 70166, Sigma-Aldrich, Germany) prepared in PBS containing 1% 
Tween was used for blocking for 30 minutes 
8- An appropriate dilution of first antibody diluted in PBS containing 1% Tween was added to 
the membrane under gentle agitation for 2h 
9-Membranes were washed 3 times (15 min each) with PBS 
10-Secondary antibody was diluted in PBS containing 1% Tween and added to membrane for 30 
min at RT with shaking 
11-Membranes were washed 3 times (15 min each) with PBS, last wash was kept until ECL 
reaction was performed on the same day.  
 
  
2.9.4 ECL Reaction 
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2 tube were equally filled with 6 ml 100 mM Tris pH 8.5, 3.3 µl 30% H2O2 was added to one 
tube and 60 µl  Luminol (250 mM in DMSO, A8511, Sigma-Aldrich, Germany) +26.6 µl p-
coumaric acid (90 mM in DMSO, C9008, Sigma-Aldrich, Germany) were added to the other 
tube.  Solutions in the two tubes were added simultaneously to the membranes and hand shaked 
with membranes for 1 min.  In a dark room, membrane was placed in a Nylon file and covered 
with medical X-ray film for few seconds or minutes (based on the experience with the antibody 
to be checked).  Finally, negative was developed using a developing machine.  If signals were 
strong, a further shorter incubation of the membrane with negative was performed, if signal was 
week, a longer incubation was performed before re-developing.  Membranes were kept at -20°C, 
stripped and blotted with another antibody if needed. 
 
 
2.9.5 Membrane Stripping 
Stripping membranes is a method used to denaturate already bound antibodies to allow the 
access and binding of new antibodies.  For this, membrane was treated for 5 min with 300 mM 
NaOH (in dH2O) shaking, washed 5 times (15 min each) with PBS before a new block with 1% 
milk or in 1% skim milk (see 2.9.3) followed and continued as mentioned in 2.9.3. 
 
2.10 Bacterial Transformation 
Transformation is the method by which naked DNA is inserted into bacterial cell.  In most cases, 
transformation is performed using competent E. coli strains BL21 and DH5 (both strains were 
kindly provided by Dr. Tchatalbachev, University of Giessen, Germany). This method is 
essential to amplify plasmid DNA. 
 
 
2.10.1 Preparation of competent bacterial cells 
Competent bacterial cells were prepared according to the classical method of Cohen et al (Cohen 
et al, 1972).  All bacteria were grown and cultured in Luria-Bertani medium (LB; 10g Bacto-
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tryptone, 5 g Yeast extract, and 10 g NaCl dissolved in 1 L dH2O and autoclaved).  An overnight 
culture from frozen stock (mix of 800 µl bacterial culture and 200 µl Glycerol frozen at -70 ˚C) 
of either BL21 or DH5 was prepared.  A 1:100 dilution (1500 µl bacteria to 150 ml fresh LB 
medium) was made regularly on the day of the experiment in Erlenmeyer flask and left to grow 
by shaking at 37 ˚C (shaker incubator; Barnstead Laboratory apparatus, USA).  Once the OD578 
reached 0.2-0.3 (normally within 1-2 h), bacterial cells were centrifuged for 10 min at 4000 rpm 
and 4 ˚C.  The supernatant was discarded completely but carefully, replaced by 30 ml ice cold 
100 mM CaCl2 and incubated on ice for 30 min.  Competent cells were re-centrifuged by 
refrigerated centrifuge for 10 min at 4000 rpm.  Finally, bacterial cells were re-suspended in 3 ml 
CaCl2 and kept on ice in 50 µl until transformation experiment or frozen at -70 ˚C after adding 
1% DMSO. 
 
2.10.2 Transformation of UL97 plasmid DNA 
1-5 µl (10-9 ng) plasmid DNA encoding Ampicillin or Kanamycin resistance gene were added to 
50 µl competent cells (see 2.10.1), mixed gently and incubated on ice for 15 min followed by 5 
min incubation at 37˚C.  This step was repeated.  400 µl LB medium was added to the mixture 
and incubated for 1 h shaking at 37˚C.  This is the step, in which the transformed cells are 
propagating.  Finally, the bacterial mixture is spread on LB-Agar containing Ampicillin (100 
µg/ml) or Kanamycin (30 µg/ml) and grown overnight at 37˚C.   
Bacterial colonies were picked on the next day and analyzed directly per PCR or grown in LB 
containing the desired antibiotic, subjected to DNA analysis followed by restriction enzyme 
analysis. 
 
 
2.11 DNA extraction from eukaryotic cells 
Viral supernatants or lysed cells were thawed and subjected to total DNA extraction using 
QIAamp DNA Mini Kit (cat#51304, Qiagen, Germany).  In most cases 200 µl of viral 
supernatant were aliquoted and subjected directly to DNA extraction, while lysed cells were 
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adjusted to 200 µl using PBS.  The extraction steps were performed according to the 
manufacturer's instructions as followed: 
1. 20 μl Qiagen Proteinase K were pipetted into the bottom of a 1.5 ml microcentrifuge 
tube.  
2. 200 μl samples were added to the microcentrifuge tube.  If the sample volume is less than 
200 μl, PBS was added to adjust the amount.   
3. 200 μl Buffer AL were added to the sample, mixed by pulse-vortexing for 15 s. 
4. Mixture was incubated at 56 ºC for 10 min followed by a short spin down  
5. 200 µl ethanol (96-100 %) were added to the sample, mixed by vortexing and briefly 
centrifuged to remove drops from the inside of the tube lid.  
6. Mixture from step 5 was applied carefully to the QIAamp Mini spin column (in a 2ml 
collection tube) without wetting the rim.  The cap was closed and column in the 
collection tube was centrifuged at 8000 rpm for 1 min.  Place the QIAamp Mini spin 
column in a clean 2ml collection tube, and discard the tube containing the filtrate.   
7. 500 μl Buffer AW1 were added to the QIAamp Mini spin column and add without 
wetting the rim and centrifuged at 8000 rpm for 1 min.  Filtrate was discarded.  
8. The QIAamp Mini spin column was replaced in a clean 2 ml collection tube, 500 μl 
Buffer AW2 were added and.  Filtrate was discarded and centrifuging step was repeated.   
9. Finally, the QIAamp Mini spin column was placed in a clean microcentrifuge tube,     
200 μl elution buffers was added to the column and centrifuged at 14000 rpm for 3 min.  
The filtrate in this step resembles the isolated DNA and was kept at -20 ºC.   
 
 
 
2.11.1 UL97 Plasmid DNA isolation (“Maxi prep”) 
For plasmid DNA isolation, transformed bacterial cells containing the desired plasmid were 
grown overnight in LB medium containing the suitable antibiotics.   For maximal preparation of 
plasmid DNA, Maxi prep was performed which requires 300 ml fresh overnight bacterial culture.  
The maxi plasmid extraction procedure was performed using Fast Ion™ Plasmid Kit (YPI25, 
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RBC Biosciences Corp., Taiwan) according to manufacturer's instructions.  A 300 ml of 
overnight bacterial culture grown in LB medium at 37 
0
C were centrifuged at 6000 rpm for 15 
minutes.  Bacterial pellet was re-suspended in 10 ml PM1 buffer (supplemented with RNase A), 
vortexed well and re-suspended in 10 ml PM2 and incubated for few minutes at RT.  The last 
steps allow the suspension to show some clearance due to the lysing action of the buffer, which 
is neutralized by adding 10 ml PM3 buffer.  The mixture is inverted 10 times and centrifuged at 
15000 rpm for 20 minutes at RT.   
Meanwhile, the provided column (PI Column) was equilibrated by applying 5 ml PEQ buffer, 
flow through was discarded and the supernatant from the neutralized bacterial solution was 
applied to the equilibrated PI Column.  The flow through was discarded and bound DNA was 
washed by 12 ml PW buffer.  Bound DNA was eluted by adding 8 ml PEL buffer, and the flow 
through DNA was precipitated by Isopropanol (75% of the eluted volume) and vortexing well.  
DNA was precipitated at 20000 rpm for 30 minutes at 4 
0
C, the supernatant was discarded, and 
the precipitate was washed by 75% ethanol, re-centrifuged (20000 rpm for 30 minutes at 4 
0
C).  
The supernatant was discarded and the precipitated DNA was allowed to air dry.  Finally, the 
DNA was re-suspended in 500 µl ultra pure water. 
 
2.12 Transfection of 293 cells 
Transfection is a method, by which naked DNA is inserted into eukaryotic cells.  Expression of 
this DNA should be detectable by different biochemical assays including WB and IF.  In this 
293T cells were subjected to transfection either in 12 well plates (for IF analysis) or in 6 well 
plates (for WB protein analysis).  Transfection was performed using the PolyFect Transfection 
reagent kit (cat#301107, Qiagen, Germany) according to the manufacturer's instruction as 
followed: 
1. Cells are seeded a day before transfection, 1x 10
5
 cells per well (6 well plate) and 1X10
4
 per 
well (12 well plate containing glass slides). 
2. Cells were incubated at 37°C and 5% CO2.  
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3. Meanwhile, 2 μg/1 μg DNA dissolved in 100 μl/50 μl serum and antibiotic free DMEM 
medium, and mixed with 20 μl/10 μl Polyfect transfection reagent at RT per well for 6 well 
plate/12 well plate.  The mixture was incubated for 5–10 min at RT to allow for complex 
formation. 
6. The complex was gently pipetted into the well on the freshly seeded cells and incubated at 
37°C and 5% CO2 for 48 h. 
 
A GFP labeled plasmid was used a positive control for transfection efficacy. 
 
 
2.13 Viral load; Real time PCR method  
Viral supernatant was thawed and total viral DNA was extracted from 200 µl sampels (see 2.10).  
DNA was either frozen at -20 °C or directly subjected to viral load analysis.  Real-time PCR for 
viral load detection was performed using an ABI Real Time PCR 7500 (applied biosystems, 
USA).  Positive controls, negative controls and samples were tested in duplicate manner.  A total 
of 20 µl reaction mixture consisted of 5µl control (positive control; standard, negative control, 
ultra pure water) or sample's DNA, 10 µl PCR master mix (Power SYBER Green, cat# 4367659, 
Applied Biosystems, United Kingdom), 1 µl of each primer (forward and reverse, each at 10 
pmol/µl, Metabion, Germany), and 3 µl ultra pure water.   
A validated viral DNA (CMVAD169, quantitated DNA PCR control, cat# 08-925-000, Abionline, 
MD, USA) was used as standard in all experiments.  The standard was serially diluted in ultra 
pure water from 10
6
 down to 10
1
 copies/µl.  
The forward and reverse primers were chosen at the Virology laboratory using the major 
glycoprotein DNA of HCMV (NC_006273.2, http://www.ncbi.nlm.nih.gov/nuccore) as a 
template after downloading it into CloneManager program.  
CMV –gb-F: 5'-CTA TCG CGT GTG TTC TAT GGC-3' 
CMV –gb-R: 5'-CAG GTG ACA TTC TTC TCG TCC-3' 
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The amplification reaction started with 2 min at 50 °C, followed by 10 min at 95°C and final 45 
cycles as following: 95°C for 15s and 60°C for 1 min followed by 15 sec at 95˚C, 1min at 60˚C, 
30 sec at 95˚C and finally 15sec at 60˚C. 
 
2.14 Amplification of UL97 gene 
UL97 gene was amplified by PCR using of 25 μl total PCR reaction which included 5.25 μl 
extracted DNA (see 2.11.1), 1μl of each primer (each 10 pmol/μl)  
5'- TGG CCG ACG CTA TCA AAT TT-3'   
5'-CGA CAC GAG GAC ATC TTG-3' (Jared et al., 2007), and 12.5 μl  PCR master mix (Ready 
Mix PCR Master Mix of Thermo scientific, Cat. No. AB-0575\Dc\LD).  The reaction was carried 
out in PCR tube (0.2 ml Axygen INC, USA) using Swift™ MaxPro Thermal Cyclers (ESCO 
Global, USA).  The PCR reaction started with a single hot start step for 5min at 95ºC followed 
by 45 cycles in the following order, 20 s at 95ºC for denaturation, 1 min at 45 ºC for annealing 
and 2 min at 72 ºC for extension respectively.  A final elongation step was performed for a 
further 10 min at 72 ºC, assuring the complete extension of the amplified product.   
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Chapter Three  
3. Results        
3.1 Induction of ER stress using Thapsigargin (TH) 
In order to detect the ability of Thapsigargin (TH) to induce ER stress, cells were 
incubated with TH containing medium for 96 h.  The induction of ER stress was 
detected using BIP antibody.  BIP is a good marker for ER stress 
detection(Buchkovich et al., 2008).  Using TH, ER stress was induced as clearly 
detectable via IF results.  The expression of BIP in TH treated cells compared with 
those untreated reflects the induction of ER stress.  
 
 
Figure 3.1: Induction of ER stress in HFF cells using TH.  HFF cells were 
incubated with TH containing media for 96 h.  Cells were then subjected to IF 
staining (see also 2.2.3) using rabbit anti BIP as first antibody diluted in 0.5% BSA 
and added to the blocked cells for 2h at RT.  After intensive washes, the 2nd antibody 
was added for 30’; Cy5 anti-Mouse (red). The nucleus was counter-stained with DAPI 
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(blue).  Staining was visualized with Olympus BX60 and Olympus DP71 digital 
camera.  
  
3.2 Induction of ER stress using TH in HCMV infected HFF cells 
In order to investigate the effect of TH in HCMV infected HFF, cells were first 
infected with AD169 for 2 h as detailed in 2.2.3.  TH containing medium was added 
at 0 hpi.  Initially the effect of TH was detected only at 72hpi and 96hpi using BIP as 
ER stress marker.  
 
 
Figure 3.2A: Kinetic induction of ER stress in AD169 infected HFF.  HFF cells 
were infected with AD169 at moi of 0.5; virus containing media was removed after 2h 
and replaced with media containing TH (TH, see drug inhibition assay, 2.3).  At 72 
hpi and 96 hpi cells were subjected to IF analysis as detailed in 2.3.  BIP antibody was 
diluted in 0.5% BSA and added to the blocked cells for 2h at RT.  After intensive 
washes, the 2nd antibody was added for 30’; Cy2 anti-Rabbit (green).  Staining was 
visualized with Olympus BX60 and Olympus DP71 digital camera. 
As clearly illustrated in figure 3.2A, ER stress was induced in infected cells in first 
picture infected but non treated with TH , but remarkably induced in TH treated 
infected cells in time dependent manner by the kinetic experiment we was do it we 
noticed theses results. The effect of TH was well reflected by the strong intensity of 
the Cy2 marker.  This clear intensity was visible in all experiments performed using 
TH in this work.  At least 100 experiments done in this work for the different co-
localizations and investigations (see below) confirmed this result constantly.  
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As clearly demonstrated via IF analysis, ER stress induction resulted in the induction 
of ER stress marker BIP.  This induction was confirmed using WB analysis in order to 
illuminate the BIP protein expression in quantitative manner. 
Hereby, HFF cells were infected with either AD169 or pUL97 deletion 
mutantUL97) or infected and treated with TH.  At 96 hpi, cell lysates were 
subjected to WB analysis using equal amount of protein as indicated via -actin 
immunobloting (see lower panel, figure 3.2B).  
 
 
Figure 3.2B:  BIP protein expression in HCMV infected cells.  HFF cells were 
infected with either AD169 or UL97 or infected and treated with TH.  At 96 hpi, cell 
lysates were subjected to WB analysis.  BIP was detected with anti Rabbit BIP 
antibody (upper panel), -actin with anti rabbit -actin antibody (lower panel), 
followed by HRP conjugated anti rabbit respectively.   
 
Figure 3.2B emphasized the results of IF analysis, showing a clear quantitative 
induction of BIP amount via immunoblot in TH treated infected cells.  Interestingly, 
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in case of UL97 infection, the BIP amount was dramatically reduced if compared 
with UL97 infected TH treated cells. There is no clear difference between AD169 
and UL97 on infected cells regarding BIP protein expression level. 
 
 
 
3.3 HFF cells during HCMV infection and TH treatment 
HFF cells are known to be the only well infected cells for in-vitro experiments of 
HCMV infection assays.  In order to test whether the cells are affected during 
infection and treatment, cells were infected with either wt-HCMV; AD169 or pUL97 
deletion mutant (UL97) as detailed in 2.2.3 and mock or drug treated using TH. 
 
 
Figure 3.3A.  HFF cells during HCMV infection and TH treatment.  HFF cells 
were either mock infected or infected with AD169 or UL97 at 0.5 moi.  Infected 
cells were either mock treated or TH treated at 0 hpi.  At 96 hpi, images were 
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captured through Olympus CKX41 inverted microscope using a regular digital camera 
(Olympus FE-46, 12 Megapixel).   
 
As clearly shown in figure 3.3A, many cells died due to infection and TH treatment.  
Although infection by itself did not reduce, cell number while HFF cells clearly 
suffered from TH treatment. 
 In order to show that the cells surviving the treatment were not structurally affected, a 
known cellular marker was used (see figure 3.3B).  Cellular AC markers are modified 
accordingly with HCMV infection (Sanchez et al 2000a, 2000b; Azzeh et al, 2006; 
Das et al, 2009).  Therefore, it will be very important to examine, whether the ER 
stress effect of TH affects Golgi in uninfected cells.  Hereby HFF cells were either 
mock treated or TH treated for 96 h.  Cells were then subjected to IF analysis using 
rabbit anti TGN (Trans Golgi network) marker (green) and counterstained with DAPI 
(nuclear staining; blue). 
 
 
Figure 3.3B: Subcellular distribution of TGN in mock treated versus TH treated 
cells.  HFF cells were either mock treated or subjected to drug inhibition using TH for 
96 h.  Treated cells, versus mock treated cells were subjected to IF analysis using 
rabbit anti TGN marker (green) and blue DAPI stain for nucleus. 
 
TGN distributed in mock non treated cells as thread like shape around the nucleus as 
expected.  In cells treated with TH, TGN was more compact but distributed similarly 
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as in mock non treated cells.  This experiment indicated that ER stress does affect or 
damage the machinery (Golgi) involved in the AC building.   
 
 
 
3.4 The role of ER stress in subcellular distribution of viral assembly 
complex (AC) marker pp28 
Figure 3.2 revealed that ER stress is induced using TH in HCMV infected cells.  Here, 
the effect of ER stress induction on HCMV viral assembly complex (AC) was 
detected using pp28 AC marker.  For this cells were infected with either wt-HCMV; 
AD169 or pUL97 deletion mutant (UL97) as detailed in 2.2.3 and mock or drug 
treated using TH.  Cells were stained for pp28 antibody and visualized using anti 
mouse Cy2. 
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Figure 3.4: Subcellular distribution of pp28 viral tegument protein in AD169 or 
UL97 infected cells.  HFF cells were infected with AD169 (upper row) or UL97 
(lower row) and subjected to drug inhibition using TH at 0 hpi.  Infected treated cells, 
versus infected mock treated cells were subjected to IF analysis using mouse anti 
pp28 and Cy2 anti mouse as secondary antibody (green). 
 
As clearly observed in 3.4, in the absence of TH, pp28 assumed its “bulb”-like 
subcellular distribution in AD169 infected cells and the crown”-like vacuole rich 
juxtanuclear structure inUL97 infected cells (Azzeh et al., 2006).  Treating infected 
cells with TH did not alter the subcellular distribution of pp28 in AD169 infected 
cells.  However, TH affected the pp28 subcellular distribution in UL97 infected 
cells.  Hereby, pp28 assumed the original “bulb”-like structure known from wt-
HCMV infected cells.  Interestingly, also the “kidney”-like shaped nucleus, typical for 
AD169 infection (Azzeh et al, 2006) was also observed in TH treated UL97 infected 
cells.  This result is an initial indication that pUL97 (gene product of UL97) may be 
important in HCMV induced ER stress.  It is also clear that the PP28 fluorescence 
signal was less intensive in both infection modes, once cells were treated with TH.  
 
 
3.5 Co-localization of BIP ER marker with pp28 viral AC marker 
In this experiment, the localization of BIP relatively to pp28 HCMV tegument protein 
was detected.  Co-localization experiments of cellular ER marker BIP with viral 
tegument protein pp28 were performed to see whether BIP is involved in AC 
building.  For this, HFF cells were infected with either AD169 or UL97 and mock 
treated or TH treated at 0 hpi.   Antibodies against both proteins; BIP and pp28 were 
used simultaneously in the IF analysis. 
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Figure 3.5: Co-localization of ER stress marker; BIP with pp28 viral tegument 
protein in D (A)/UL97 (B) infected cells.  HFF cells were infected with 
Dor UL97 (B) and subjected to drug inhibition using TH at 0 hpi.  
Infected treated cells, versus infected mock treated cells were subjected to IF analysis 
using rabbit anti BIP as first antibody and anti rabbit Cy5 as secondary antibody (red) 
or mouse anti pp28 and Cy2 anti mouse as secondary antibody (green). 
In respect to co-localization, pp28 does not co-localize with BIP in either virus 
infected cells.  This fact was constant when cells were treated with TH.  A partial co-
localization was observed only in some cells.   
 
3.6 Co-localization of other ER marker Calnexin with pp28  
Further ER markers were tested for their possible involvement in the AC building.  
Calnexin is one of these candidates, since it is an integral protein of the ER.  As the 
case for other ER resident proteins, Calnexin acts as a molecular chaperone and 
participate in the proper folding of polypeptides.  For co-localization experiments of 
Calnexin with pp28, HFF cells were infected with either AD169 or UL97 and mock 
treated or TH treated at 0 hpi.   Antibodies against both proteins; Calnexin and pp28 
were used simultaneously in the IF analysis. 
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Figure 3.6A: Co-localization of Calnexin with pp28 viral tegument protein in 
D infected cells.  HFF cells were infected with D and subjected to drug 
inhibition using TH at 0 hpi.  Infected treated cells, versus infected mock treated cells 
were subjected to IF analysis using rabbit anti Calnexin as first antibody and anti 
rabbit Cy5 as secondary antibody (red) or mouse anti pp28 and Cy2 anti mouse as 
secondary antibody (green). 
 
Figure 3.6B: Co-localization of Calnexin with pp28 viral tegument protein in 
UL97 infected cells.  HFF cells were infected with UL97 and subjected to drug 
inhibition using TH at 0 hpi.  Infected treated cells, versus infected mock treated cells 
were subjected to IF analysis using rabbit anti Calnexin as first antibody and anti 
rabbit Cy5 as secondary antibody (red) or mouse anti pp28 and Cy2 anti mouse as 
secondary antibody (green). 
 
The co-localization experiments illuminate clearly, that ER marker Calnexin does not 
co-localize with pp28 at the AC. Furthermore, the experiments showed that the 
subcellular distribution of Calnexin was not clearly affected by ER stress induction 
using TH in either infection cases (AD169 or UL97).   
 
3.7 Co-localization of other ER marker EEA1 with pp28  
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ER markers EEA1 was reported earlier to co-localize to the center of the AC (Das et 
al., 2007).  Here, the co-localization of EEA1 to the AC using pp28 AC marker was 
detected under ER stress condition in wt and in UL97 deletion mutant infected cells. 
EEA1 (early endosomal antigen 1) is specific to early endosome and essential for 
fusion between early endocytic vesicles. Early endosomes are cytoplasmic 
compartments which fuse with endocytic vesicles for redistribution of extracellular 
compounds to alternate destinations. 
For this co-localization experiments of EEA1 with pp28, HFF cells were infected with 
either AD169 or UL97 and mock treated or TH treated at 0 hpi.  Antibodies against 
both proteins; EEA1 and pp28 were used simultaneously in the IF analysis. 
 
 
 
Figure 3.7A: Co-localization of ER stress marker; EEA1 with pp28 viral 
tegument protein in D infected cells.  HFF cells were infected with D and 
subjected to drug inhibition using TH at 0 hpi. Infected treated cells, versus infected 
mock treated cells were subjected to IF analysis using rabbit anti BIP as first antibody 
and anti rabbit Cy5 as secondary antibody (red) or mouse anti pp28 and Cy2 anti 
mouse as secondary antibody (green). 
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Figure 3.7B: Co-localization of ER stress marker; EEA1 with pp28 viral 
tegument protein in UL97 infected cells.  HFF cells were infected with UL97 
and subjected to drug inhibition using TH at 0 hpi. Infected treated cells, versus 
infected mock treated cells were subjected to IF analysis using rabbit anti BIP as first 
antibody and anti rabbit Cy5 as secondary antibody (red) or mouse anti pp28 and Cy2 
anti mouse as secondary antibody (green). 
 
The results presented here demonstrated that EEA1 did indeed co-localize to the AC 
and mainly to the center of the AC in wt infected cells. Interestingly, the co-
localization in UL97 infected cells was very limited in untreated cells, but obvious in 
UL97 infected treated cells.  This is further evidence that strengthen the point that 
UL97 plays a role in ER stress. 
 
3.8 The role of ER stress in subcellular distribution of pp65  
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pp65 is an early late protein and the major tegument protein of HCMV (see 1.3.3.1) 
and co-localizes to the AC.  Here, we were interested in investigating the effect of ER 
stress induction on pp65 in AD169, as well as in UL97 deletion mutant.  HFF cells 
were infected by either AD169 or UL976 and mock treated or treated by TH at 0 
hpi.  Infected cells were subjected to IF analysis at 96 hpi using anti mouse pp65 
followed by anti mouse Cy2.    
A
 
 
 
B
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Figure 3.8:  Subcellular distribution of pp65 in D (A) or UL97 (B) infected 
mock treated versus TH treated cells.  HFF cells were infected with D (A) or 
UL97 (B) and subjected to drug inhibition using TH at 0 hpi.  Infected treated cells, 
versus infected mock treated cells were subjected to IF analysis using mouse anti 
pp65 and Cy2 anti mouse as secondary antibody (green). Nucleus was counterstained 
with DAPI. 
 
pp65 is known to distribute within the nucleus in the first 48 hpi in cells infected with 
either D or UL97, however it localizes clearly to the cytoplasm after 72 hpi.   
Interestingly, inducing ER stress using TH retarded pp65 clearly in the nucleus at 96 
hpi in most infected cells.  This result indicated that ER stress delays nuclear egress of 
viral early late gene proteins.  
So far, we were able to detect different viral proteins using IF analysis, however, 
these results did not reflect the quantitative status of these proteins.  pp65 is the major 
tegument protein and involved in AC building (Prichard et al, 2005, Azzeh et al., 
2006).  Therefore, pp65 was quantitatively detected using WB analysis in either mock 
treated or TH treated AD169 or UL97 infected HFF cells.  
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Figure 3.8C: Tegument protein pp65 expression during ER stress.  HFF cells 
were infected with either AD169 or UL97 or infected and treated with TH.  Equal 
amounts of total protein lysates were subjected to western blot analysis at 96 hpi.  
pp65 was detected with anti mouse pp65 (upper panel), -actin with anti rabbit -
actin (lower panel), followed by either anti rabbit or anti mouse HRP respectively.   
 
Figure 3.8C showed surprisingly that a clear reduction in pp65 expression occurred in 
TH treated cells (see pp65 immunoblot, upper panel).  Furthermore, pp65 expression 
was also reduced in UL97 infected cells if compared to AD169 infected cells.  -
actin was used to ensure that equal amounts were loaded on gel are equal (protein 
loading control). 
   
3.9 The influence of ER stress on early genes  
Our results revealed that HCMV assembly proteins were clearly affected by inducing 
ER stress, therefore it was essential to check, whether ER stress may also affect early 
genes.   Early genes are those HCMV viral genes, which are expressed within the first 
hours of infection, i.e. 24 hpi and do not redistribute to the cytoplasm.  An example of 
these genes is IE1/2 (immediate early protein 1 and 2).   HFF cells were infected as 
above and subjected to IF analysis using mouse anti IE1/2.  
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Figure 3.9A:  Subcellular distribution of IE1/2 in D infected mock treated 
versus TH treated cells.  HFF cells were infected with D and subjected to drug 
inhibition using TH at 0 hpi.  At 96hpi infected treated cells, versus infected mock 
treated cells were subjected to IF analysis using mouse anti IE1/2 and Cy2 anti mouse 
as secondary antibody (green).  Nucleus was counterstained with DAPI. 
 
Figure 3.9B: Subcellular distribution of IE1/2 in UL97 infected mock treated 
versus TH treated cells.  HFF cells were infected with UL97 and subjected to drug 
inhibition using TH at 0 hpi.  At 24hpi infected treated cells, versus infected mock 
treated cells were subjected to IF analysis using mouse anti IE1/2 and Cy2 anti mouse 
as secondary antibody (green).  Nucleus was counterstained with DAPI. 
 
Detecting early gene IE1/2 in infected cells revealed that its subcellular distribution 
was not affected in TH treated cells, if compared to mock treated cells.  These results 
indicated that viral immediate early genes are not targeted by ER stress induction. 
 
3.10 ER stress effect on viral titer and viral DNA load 
Viral titration assays were performed, in order to assess the influence of TH on viable 
progeny viruses using the traditional plaque assay method (see 2.2.2).  Cells were 
hereby subjected to infection assay using AD169 or UL97, mock inhibited or TH 
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inhibited in drug inhibition assay.  Supernatants were subjected to plaque assay 
analysis at 96 hpi.  The viral titer was strikingly reduced in the TH treated AD169 
infected cells compared to TH inhibited UL97 infected cells (figure 3.10).  In the 
first case the viral titer was reduced almost 3 log, but only less than 0.5 log in the 
second case (figure 3.10).  
 
 
 
Figure 3.10A: Influence of TH on Viral Titration.  HFF cells were infected with 
either AD169 or UL97 and either subjected to drug treatment or mock treated.  At 
96 hpi viral supernatants of treated versus mock treated infected cells were subjected 
to plaque assay.  Plaques were counted from 3 different experiments; Log 10 of viral 
titers is given on the Y axis and infection condition on the X axis.    
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Figure 3.10B:  Influence of moi and TH on HCMV viral load.  HFF cells were 
infected with different moi of AD169 and mock treated or TH treated using drug 
inhibition assay.  Supernatants were collected at 96 hpi and subjected to DNA 
extraction followed by RT-PCR.  Calculated Log10 of quantities is given on the y 
axis and moi on the x axis.   
The viral load was determined in infection or drug “inhibition” assays using different 
viral moi, to see whether the TH affects the cells or the virus directly. 
As clearly indicated in figure 3.10B, TH reduced the viral load overall, however, this 
reduction was lower when less moi was used.  While the viral load was reduced 1.5-2 
log at moi 0.3-1, it was only reduced 0.5-1 log at moi 0.03-0.15 respectively.   
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Chapter Four 
4. Discussion 
In the struggle between viruses and host cells, taking control over the cell’s death machinery is 
very crucial for survival.  Several viruses, including human cytomegalovirus (HCMV) induce ER 
stress and activate UPR signaling (Goodrum et al., 2002; Su et al., 2002; Tardif et al., 2002; Isler 
et al., 2005a).  Due to the 96 hours long life cycle of HCMV, the virus needs to keep the cell 
functioning at least for its life cycle period and avoid any detrimental effects of cellular stress.  
The role of the viral UL97 kinase activity and assembly complex in HCMV induced ER stress 
was not elucidated yet.  Our data provides evidence for the influence of induced ER stress on 
HCMV assembly complex and a role of the viral UL97 kinase in modulating this HCMV 
induced ER stress. 
 
4.1 Influence of TH induction on BIP and HFF cells 
In order to verify the role of ER stress and UL97 on the HCMV life cycle, we used Thapsigargin 
as ER stress inducer.  Initially we demonstrated that treating HFF cells with Thapsigargin indeed 
induced ER stress using BIP as ER marker.  It is known that BIP is induced by HCMV at early 
phase of infection within the first 48 postinfection (Isler et al, 2005a), in order to prevent UPR 
activation (Isler et al., 2005a).  At late phase of infection, HCMV was reported to target BIP 
degradation to allow the UPR activation (Isler et al., 2005a).  Furthermore, the increase in BIP 
levels was also shown to play a role in building HCMV assembly complex and egress 
(Buchkovich et al., 2008; 2009).  
 
  
4.2 ER stress response and continuous BIP induction 
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In order to test the effect of continuous BIP induction and thus UPR activation, we treated 
HCMV infected cells with Thapsigargin.  At 96hpi, BIP expression was still induced in 
Thapsigargin treated infected cells, indicating successful continuous ER stress.  This was 
demonstrated by both, IF and Western blot analyses using BIP specific antibody.  The induction 
of ER stress using TH was further investigated in respect to HFF viability.  Direct capture of 
cells infected and subjected to TH treatment showed no evidence for changes in monolayer 
structure.  It is essential in these experiments to exclude the direct effect of TH on cells and cell 
structure.  A further evidence was made using a golgi marker in HFF cells versus TH treated 
HFF cells.  The golgi structure was not affected by TH treatment nor was it dispersed or 
depleted.  
 
     
4.3 The influence of ER stress induction on assembly complex 
The subcellular distribution of HCMV assembly complex had been shown earlier to be a “bulb” 
like juxtanuclear structure, where viral tegument and glycoproteins as well as cellular Golgi and 
ER proteins are co-localized (Sanchez et al., 2002a; Sanchez et al., 2000b; Azzeh et al., 2006).  
The formation of this assembly complex is a prerequisite for production of mature progeny of 
HCMV virions. Treating cells with Thapsigargin did not affect the assembly complex formation, 
or the co-localization known pattern of viral and cellular proteins.  However, it led to a decrease 
in the IF intensity signals of the “bulb” like structure (figure 3.4, 3.5 and 3.6).  This might be the 
mechanism caused by which viral load and viral titer were reduced as shown in figures 3.10A 
and B (discussed below in 4.5).   
It is known that inhibition of translation may permit cells to recover from stress, but would not 
benefit HCMV replication.  The slow replicative cycle characteristic for HCMV requires the 
virus to maintain the host cell in a metabolically and translationally active state for an extended 
period; thus HCMV is obliged to abrogate this type of cellular response. A number of studies 
have shown that HCMV infection induces several mechanisms to overcome the negative effects 
of stress responses and maintain translation (Child et al. 2004; Kudchodkar et al. 2004; Hakki 
and Geballe 2005; Isler et al. 2005a, 2005b; Walsh et al. 2005; Hakki et al. 2006; Kudchodkar et 
58 
 
al. 2006; Kudchodkar et al. 2007).  Showing that Thapsigargin induced ER stress resulted in 
assembly complex malformation reflects the fact that continuous ER stress inhibited the active 
metabolically and translationally state for an extended period.  Inhibition may be due to the fact 
that the virus is in need to complete its life cycle.  Although inhibition was clearly obvious using 
pp28 as viral assembly complex and true late protein, inhibition was very drastic for the early 
pp65 protein as demonstrated by western blot analysis (see below). 
Immunofluorescence assays suggested that the site of cytoplasmic envelopment is a juxtanuclear 
structure that includes viral tegument proteins as well as multiple virus-encoded envelope 
proteins (Sanchez et al, 2002a,b).  Using antibodies to cellular proteins, the cytoplasmic 
assembly complex has been shown to partially overlap with a component of the trans-Golgi 
network (Sanchez et al, 2002a, b; Azzeh et al., 2006; Das et al., 2007).  Interestingly, although 
pp28 subcellular localization was not changed, as shown in TH treated cells, we observed a 
decrease in pp28 fluorescing signal in immunofluorescence assays due to TH treatment.  These 
results evoked the possibility that TH leads to a decrease in pp28 expression levels in HCMV 
infected HFF.  Moreover, these results can explain, at least in part, that the decrease in pp28 after 
TH is responsible for lowered viral titer (see below 4.4).  
A further indication for a possible influence of ER stress on the assembly complex was 
eliminated in pp65 detection via immunofluorescence as well as via immunoblot.  The 
immunofluorescence experiments detecting pp65 show an unfortunate retardation of pp65 in the 
nucleus.  This could be one of the indirect effects of ER stress on the assembly complex 
formations as pp65 is one of the AC components (Prichard et al., 2006; Zawahreh et al., 2008; 
Qawasmi et al, 2011).  More drastically was the pp65 protein expression detected under ER 
stress induced by TH.  The levels of pp65 expression decreased more than 100X in AD169 
infected HFF treated with TH and was not detectable in UL97 infected HFF after TH treatment.  
This is a further evidence for the influence of ER stress on the HCMV assembly complex, which 
has a consequence on replication and the formation of viral particles.  
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4.4  Influence of ER stress on early genes 
Detecting early gene IE1/2 in infected cells revealed that its subcellular distribution was not 
affected in TH treated cells, compared to mock treated cells.  This result indicated that ER stress 
affected early late (48 hours post infection) to late viral genes only, which are involved in the 
later phase of HCMV life cycle.  In other words, ER stress affected mainly late phase of HCMV 
infection cycle. 
 
4.5  The influence of ER stress on ER markers in HCMV infected cells 
The co-localization experiments illuminated clearly, that ER marker Calnexin does not co-
localize with pp28 at the AC of HCMV infected cells.  Furthermore, the experiments showed 
that the subcellular distribution of Calnexin was not clearly affected by ER stress induction using 
Thapsigargin in either infection cases (AD169 or UL97).  Similar results were also observed 
for BIP, although partial co-localization was observed occasionally.  Both calnexin and BIP are 
chaperone proteins.  BIP was actually reported to play a role in building AC in HCMV infected 
cells (Buchkovich et al., 2008; 2009).  However, its co-localization with HCMV AC components 
was not demonstrated.  
On the other hand, our results demonstrated that EEA1 did indeed co-locale to the AC and 
mainly to the center of the AC in wt infected cells.  This is in line with previous a previous study, 
which revealed that EEA1 is a component of the HCMV AC (Das et al., 2007).  The co-
localization however, was affected in UL97 infected cells and was one of the factors supporting 
our proposal in regard to the role of UL97 kinase in ER stress are implicated below. 
 
4.6 The role of UL97 in modulating ER stress 
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Although the intact UL97 open reading frame is not essential for viral replication, its deficiency 
reduces virus yield by more than 2 orders of magnitude (Prichard et al., 1999).   
Here we provided convincing evidence for the involvement of UL97 in ER stress in HCMV 
infected cells.  Our results show that while BIP protein was induced in AD169 as well as in 
UL97 infected cells.  This result indicated that UL97 is involved in cellular ER stress induction.  
This could be a critical factor for HCMV replication and life cycle completion.  Moreover, our 
results clearly showed that UL97 affected pp28 subcellular distribution of pp28 AC marker in 
infected cells, treated with TH.  Hereby, pp28 assumed the original “bulb”-like structure known 
from wt-HCMV infected cells.  Interestingly, also the “kidney”-like shaped nucleus, typical for 
AD169 infection (Azzeh et al, 2006) was also observed in Thapsigargin treated UL97 infected 
cells.  Additionally, the co-localization of EEA1 with AC marker in UL97 infected cells was 
very limited in TH untreated cells, but obvious in treated cells infected with wt AD169.   
Furthermore, pp65 protein expression was drastically reduced in UL97 infected cells if 
compared to AD169 infected cells.  Altogether, these experimental facts strengthens the idea that 
UL97 kinase may play an essential role in HCMV induced ER stress. 
 
4.7 ER stress and viral titration 
Viral plaque assays showed clearly that treating infected cells with TH had a critical influence on 
mature virion production.  This indicated that the influence of ER stress on the viral proteins 
discussed above was only a part of the ER stress consequences on HCMV.  Determination of 
viral titer via plaque assays is based on the detection of mature infectious virion particles, which 
are able to produce plaques.  The decrease in viral titer in TH treated infected cells were in 
agreement with previous studies (Isler et al., 2005b).   Electron microscopic (EM) analysis had 
shown that TH severely disrupted the maturation of HCMV virions (Isler et al., 2005b). 
 
4.8 HCMV DNA detection by viral load assay 
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On the contrary, viral load experiments showed less drastic decrease in HCMV DNA detected in 
TH treated infected cells.  The reason is that even DNA of defected viruses can be detected viral 
Real time PCR and not only mature infectious virions as the case with plaque assays.  
Nevertheless, viral load detection revealed that the TH effect is clearly dependent on the viral 
titer used initially for infection.  Furthermore, these results are further evidence for the arguments 
discussed in 4.1 that TH affects infected cells rather than mock infected cells, as the decrease in 
viral DNA detected in TH treated cells was less prominent in cells infected with low moi.  
 
4.9 Conclusions 
The experimental set up presented here provided an insight in the field of viral-cellular 
interaction research.  The basics of measurement of ER stress induction with TH were in line 
with previously published data, making it a solid platform to peruse the research questions 
proposed here.  
The involvement of viruses with this massive cellular response (ER stress) had shed a light on 
various aspects of viral/cellular interaction and the potential of infection under such cellular 
circumstances. 
The data presented here provided evidence for the involvement of viral tegument proteins pp28, 
pp65 and pUL97 in ER stress.  ER stress indeed affected the AC complex especially in UL97 
infected cells.  Building on this initial evidence, the possible role of the only viral kinase UL97 
in ER stress was evoked.  It became clear that pp28 and pp65 were probably part of the tools for 
UL97 modulating the ER stress for the best benefit of the viral replication cycle.  Finally, 
identifying its role in ER stress, our results elucidated that the various functions of the only 
HCMV kinase were not exploited yet, and still a subject for further research.   
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 تأثير أجهاد الشبكة الأندوبلازمية على مركز تجمع الفيروس و دورة حياته: العنوان
 ميساء محمود حسن صلاح: أعداد
 الدكتورة ميساء العزة: أشراف
  ملخصال
 بما فيروسات،العديد من ال. الفيروس بقاء أجل من الأهمية بالغ ا  أمر  الخلية موت آلية على السيطرةتعد  ة بفيروسعند الاصاب
. )RPU(وبروتينات تسمى  )RE – muluciteR cimsalpodnE( الاندوبلازمية الشبكةتحفز اجهاد  )VMCH( فيروس هافي
هذه  إجهاد تأثيرولكن   ،مع هذا الفيروس تحديدا  من جوانب عدة  ميةالاندوبلاز  الشبكة إجهاد ولقد تم دراسة العلاقة بين
 .مركز تجمع الفيروس لم يتم ايضاحه تماما على الشبكة
إن مرّكز تجمع الفيروس . الاندوبلازمية الشبكة إجهادب يتعلق فيما الفيروس حياة دورة من واحد جانب على العمل هذا يركز 
 خلايافي ال )VMC( فيروس حياة دورةن لأ نظرا  و . عملية التكاثر لبدء الفيروسية البروتينات فيه تجميع يتمالذي  الموقع هو
 أي تجنبيو  الأقل على حياته دورة طوالالخلية  عمللأن يحافظ على  بحاجة الفيروس فإن ساعة، 96تمتد إلى  البشرية
 .الخلوي لإجهادل ضارة تأثيرات
 مقابلفي  الفيروسب المصابة خلاياال في الاندوبلازمية الشبكة لإجهادكمحفز  nigragispahTفي هذه الدراسة تم استخدام 
باعتبارها نموذج  الإصابة لفحوصات )FFH(البشرية  لقلفةل الليفية الخلايا واستخدمت. وهميةإصابة  مصابةخلايا أخرى 
تسمى ب وسلالات أخرى 961DA استخدمنا سلالات برية من الفيروس تسمى ب . هذا الفيروس عدوىدراسة ل ناجح مخبري
وبالتالي  ،الوحيد في هذا الفيروس  المفسفر هو 79LUإن . والتي تملك طفرة جينية تجعلها تفتقر الى الانزيم المفسفر  79LU
 الفيروسية بروتيناته يقوم بفسفرة كل من الأنأظهرت دراسات سابقة  وقد للفيروسات، المضادة لأدويةفهو الهدف الرئيسي ل
 علىقد أثر  الاندوبلازمية الشبكة إجهاد أن النتائج التي حصلنا عليها أظهرتو . العدوىالإصابة ب وبالتالي تسهيل والخلوية
 تغير فيكان مشاركا   )79LUp( الفيروسي أن اهذا المفسفر لاحقة تجارب كشفتو . و بروتينات مركز تجمع الفيروس مكان
هذا  من التحقق وتم. ه أثر على مركز تجمع الفيروس ، كمية ومعيار الفيروس بالجسمالشبكة الاندوبلازمية الذي بدور  إجهاد
 nretsew تم فحص هذا البروتين  بتقنية  ، بروتينات مركز تجمع الفيروسوهو أحد  56ppفحص بروتين  طريق عنالتأثير 
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وهو مؤشر  PIB عين الاعتبار أن الكما أن الدراسة أخذت ب. المهم البروتين هذا على مهمة تأثيرات كشفت والتي tolb
 .لاجهاد الشبكة الاندوبلازمية قد اسُتِحث بشكل يتناسب مع التأثير الحاصل على مركز الفيروس
الاندوبلازمية يشكل حقلا  علميا  قائما  بذاته، وقد ساهم التدخل الكبير لهذه الفيروسات في نظام التفاعل  الشبكة إن إجهاد
الى إلقاء الضوء على العديد من الجوانب في بحوث التفاعل الفيروسي مع النظام الخلوي وفي مجال  والاستجابة في الخلايا
بواسطة (وتقدم البيانات التي تعرض هنا برهانا  واضحا  على مشاركة بروتينات مركز التجمع الفيروسي . العدوى واحتماليتها
 .الاندوبلازمية الشبكة في إجهاد )79LUالمفسفر 
 
